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ABSTRACT 
 
Background: 
Chronic obstructive pulmonary disease (COPD), characterised by progressive airflow limitation 
which is not fully reversible and associated with pulmonary and systemic inflammatory processes, 
is largely associated with smoking and is classified as a disease of lifestyle. Other factors related to 
the incidence of COPD are passive smoking, the inhalation of gases from biomass fuels and the 
genetic abscence of the protease alpha1-antirypsin in some people. COPD is found in all sectors of 
society and is not dependent on level of income or on the global location of a population. 
Compounding the incidence of COPD in Africa is the human immunodeficiency virus/ acquired 
immunodeficiency syndrome (HIV/AIDS) that predisposes patients to the development of COPD. 
Hydrotherapy has been used since ancient times as a preventative and/or therapeutic form of 
treatment. Physiotherapists have used hydrotherapy alone or as a useful adjunct to other treatment 
options for years. Today aquatic therapy is practised in many centres where a multi-disciplinary 
approach to this form of treatment is offered. There are a number of methodologies of application 
of the therapy. Among these are Ai Chi, Halliwick, Watsu and Bad Ragaz. The treatment takes 
place in thermoneutral water between 29 degrees centigrade (oC) and 34oC where use is made of 
the buoyancy and/or resistance created by the aquatic medium. Musculoskeletal conditions, 
including pre-operative total hip and knee replacements; osteoarthritis and rheumatoid arthritis can 
be treated with this modality. Hydrotherapy affords athletes a non-weightbearing rehabilitative 
environment to enable a quicker recovery and also enables cardiovascular reconditioning to 
commence sooner than would be afforded by a land-based rehabilitation programme. Many 
chronic conditions, including cardiac failure, stroke and metabolic disorders have benefited from a 
hydrotherapy intervention. COPD has been shown to have an inflammatory component. Exercise 
on land has been shown to have an anti-inflammatory effect in healthy individuals but increased 
levels of tumour necrosis factor–alpha (TNF-alpha), known to be associated with inflammation, has 
resulted from moderate intensity land-based exercise in patients with COPD.  
 
Aim and objectives of the research: 
The aim of this study is to systematically review the evidence related to the role of hydrotherapy in 
the management of patients with COPD. The research objectives of this study are: to determine, 
from the literature, whether water temperature and depth of immersion influences cardiopulmonary 
function in patients with COPD; to determine, from the literature, whether hydrotherapy increases 
endurance, function and quality of life (QoL) in patients with COPD and to determine, from the 
literature, whether the anti-inflammatory effects of water-based exercise in patients with COPD 
have been documented. 
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Method: 
The study design is a qualitative systematic review. A search was made for relevant journal articles 
in the PUBMED, SCOPUS, CINAHL, MEDLINE, SPORTSDiscus and Cochrane review databases. 
Google scholar was perused in order to find any grey literature pertaining to the population under 
review.The review of the literature was from 1996 until 2009. This protracted period of 13 years 
was needed to insure that all leading articles on the subject under review were included in the 
review. There were too few articles available from 2000 onwards to produce a valid review of the 
topic.The words and/or phrases used in the search were: hydrotherapy, Halliwick, Ai Chi, Watsu, 
Bad Ragaz, chronic obstructive pulmonary disease (COPD), pulmonary rehabilitation, emphysema, 
chronic bronchitis and the anti-inflammatory effects of exercise. Articles in the form of systematic 
reviews, randomised controlled trials, clinical trials and case studies pertaining to adult patients 
with non-acute, non-terminal COPD and the use of hydrotherapy were included in this review. No 
articles based on animal studies were included. No articles on Kneipp therapy were included as 
hydrotherapy in this format does not include the immersion of the patient in water.The LOW (Lewis, 
Olds and Williams, 2007) critical appraisal tool was used to evaluate the articles included in the 
systematic review. 
 
Results: 
Thirty-seven studies were sourced and nine studies were included in the qualitative systematic 
review. A total of 35 outcomes measures were reported within the nine included studies. They 
were of a varied nature and therefore were grouped into the following categories: cardiovascular; 
pulmonary; muscle strength/weakness; endurance and power, QoL and activities of daily living 
(ADL). Beneficial results were found in relation to heart rate (HR) with a regime of upper limb 
exercises performed in water. Following an upper body and upper limb 15 minute land-based 
exercise programme and subsequent 10-15 minute rest period on land, systolic blood pressure 
(SBP) was decreased by 14mmHg and diastolic blood pressure (DBP) by 6 mmHg (compared to 
resting land values) when patients with COPD were immersed in 32 oC water. Ejection fraction 
(EF) improved significantly at the end of a two month breathing exercise programme in water. A 
water-based intervention period of 120 minutes (20 minutes, six days/week for two months) 
decreased left ventricular end –diastolic (LVd) and left ventricular end-systolic (LVs) dimensions 
(p<0.01). Exhaling into water, during an aquatic breathing exercise regimen lasting 30 
minutes/day, six days/week for two months, was demonstrated to significantly increase percentage 
predicted forced expiratory volume in one second (FEV1%). Arterial concentration of carbon 
dioxide (PaCO2) levels were decreased significantly due to the breathing exercise with exhalation 
into water regimens and during the breathing out into water intervention for 20 minute /day for six 
days the arterial concentration of oxygen (PaO2) levels were increased. Peak flow (PF) was 
improved in all the breathing programmes where the patient exhaled into water. Improvement in 
respiratory rate (RR) and oxygen saturation (SaO2) were seen, in patients with COPD, who 
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performed weight -resisted upper limb exercises in water once a week with a twice weekly 
pulmonary rehabilitation programme (PRP) on land as opposed to a land-based PRP three times 
per week.Two of the included studies recorded improvement in the incremental shuttle walk test 
(ISWT) following exercise in water and one noted a greater improvement in the endurance shuttle 
walk test (ESWT) than in the ISWT after hydrotherapy. Maximal dynamic flexion showed marked 
improvement after an aquatic programme. Physical and cardiopulmonary improvements, including 
reduced levels of dyspnoea in some instances, were reported and these were linked to increased 
levels of physical conditioning, better QoL and improved ability to undertake ADL in the patients 
with COPD. 
 
Conclusion: 
Breathing exercises, where the patients exhale into the water, appear to have a beneficial effect on 
pulmonary outcomes particularly when the programme is of a duration of120 minutes per week or 
more and the exercise is performed on six days / week.The physical exercise hydrotherapy 
programmes address some of the muscular weaknesses resulting from  the systemic effects of 
COPD. Both the cardiopulmonary benefites and physical benefits seem to result in a general 
improvement in the QoL of the patients and their greater ability to perform ADL. Social interaction 
and psychological well-being seem to be factors related to increased compliance in hydrotherapy 
exercise programmes when compared to compliance in land-based programmes.No information 
was retrieved from the included studies relating to the anti-inflammatory effects of hydrotherapy 
exercise programmes. No randomised controlled trials were sourced on the subject under review. 
The overall evidence was of variable quality, with three studies above average, two average and 
four below average, according to the LOW critical appraisal tool. From the results obtained in the 
review it became apparent that there is an urgent need for a number of randomised controlled trials 
to investigate the role of breathing exercises in combination with physical exercise programmes of 
hydrotherapy in the management of COPD so that this form of therapy can be utilised to its full 
capacity. 
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CHAPTER 1 
1. INTRODUCTION 
 
1.1  BACKGROUND 
Longterm exposure to smoking, sedentary habits, unhealthy diets and possibly stress have 
been mentioned by the South African Medical Research Council (SAMRC) as risk factors 
for the development of a group of diseases termed chronic diseases of lifestyle (SAMRC, 
2008). The World Health Organisation (WHO) and World Bank Global Burden of Disease 
Study statistics (1990), as reported by Pauwels et al (2001), showed the estimated 
prevalence of chronic obstructive pulmonary disease (COPD) in the world as 9.34/1000 in 
the male population and 7.33/1000 in the female population. The issue of COPD in the 
elderly was addressed in a study by Buist et al (2007) who concluded that the prevalence of 
the disease was strongly determined by age and smoking. They suggested that public 
health authorities would have to take these and other causative factors into consideration 
when designing preventative measures at a primary and/or secondary level. In a Burden of 
Obstructive Lung Disease (BOLD) study, looking at the prevalence of COPD in different 
international populations, 12 study sites were utilised (Buist et al, 2007). A high prevalence 
of COPD was found in Cape Town, South Africa (Mannino and Buist, 2007). In the South 
African Demographic and Health Survey (SADHS) (1998) data that emerged from 
developing countries showed that the incidence of non-communicable diseases (NCD), 
which are usually linked to a wealthier population, are as high in poorer nations (Schneider 
et al,2009). Beaglehole and Yach (2003) pinpointed the fact that, in poorer populations, the 
rate of globilisation has outstripped the national and international reaction to this 
phenomenon which resulted in the subjection of struggling health services in such 
communities to further pressure due to the increase in the occurrence of NCD. Hence Yach 
(2002) suggested the need for health services to transform in order to meet the chronic 
care requirements of the poor. His suggestions included increased efforts to decrease risk 
factors for the development of these diseases with a focus directed towards primary care. 
Emphasis was placed on the fact that risk prevention and early intervention in the treatment 
of chronic diseases would reduce the burden of NCD on healthcare services in developing 
countries. People in poorer communities tend to be more likely to suffer from chronic 
bronchitis (Schneider et al, 2009) due to their greater risk of exposure to extraneous smoke 
from fuels used at home.They tend to be more prone to smoking although the number of 
cigarettes smoked per capita is less than that seen in the wealthier sector of the population 
(Schneider et al, 2009). According to the WHO (Assembly document A61/8, 2008) by the 
year 2020 chronic diseases “are expected to account for 73% of deaths and 60% of the 
disease burden worldwide.”  COPD will rank as the third most common cause of death 
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worldwide by 2020 (Heaney, Lindsay and McGarvey, 2007). The WHO “Tobacco Atlas” 
(2002) showed that males are heavier smokers than females worldwide. Approximately one 
billion men smoked globally whereas daily female smokers numbered nearly 250 million. A 
higher percentage of men (50%) in developing countries smoked compared to those in 
developed nations (35%). 
 
Airflow limitation which is not fully reversible with treatment characterises pulmonary 
COPD. The progressive nature of the decrease in airflow is linked to abnormal 
inflammatory processes in the lungs associated with exposure to noxious gas particles. The 
severity of the disease in some patients may be due to its extra-pulmonary effects. COPD 
is preventable and treatable (Pauwels et al, 2001; Barnes, 2003; The Global Obstructive 
Lung Disease (GOLD) guidelines, 2005; Stockley, Mannino and Barnes, 2009). Murărescu, 
Mitrofan and Mihailovici (2007) stated that COPD is an umbrella term for emphysema, 
chronic bronchitis and a category of asthma. The signs and symptoms exhibited by patients 
who have COPD are related to whether the obstruction in the airways is due to 
emphysema, chronic bronchitis or severe, chronic asthma. Patients with COPD often have 
a combination of the emphysematous and chronic bronchitis changes in their lungs and 
their symptoms reflect a mixed pattern of disease. Chronic bronchitis manifests with 
obstruction of the smaller airways and fibrosis and is characterised by a chronic productive 
cough which lasts for a period of three months and is present for two years in a row 
(Murărescu, Mitrofan and Mihailovici, 2007). Emphysema is associated with destruction of 
lung parenchyma, breakdown of alveolar structures leading to enlarged airspaces, a loss of 
lung pliability and premature closure of small airways during expiration and forced 
expiration in particular (WHO, 2005). A chronic, productive cough is found in patients who 
suffer from emphysema and/or chronic bronchitis. Smoking is described as the main risk 
factor for the development of COPD (Mannino et al, 2006; Stockley, Mannino and Barnes, 
2009). Environmental and occupational exposure to air pollutants factors predisposes to an 
increased risk of developing the disease (Stockley, Mannino and Barnes, 2009). Bronchitis 
or pneumonia in infancy can predispose to a mean reduction in forced expiratory volume in 
one second (FEV1), adjusted for age and height in adult men. These data support a 
possible causal connection between COPD in later life and lower respiratory tract infections 
in early childhood (Shaheen, Barker and Holgate, 1995). In non-smokers links have been 
established between the inhalation of smoke from the combustion of biomass fuels and the 
development of COPD (Salvi and Barnes, 2009). Passive smoking is noted as a causative 
factor in the worsening of existing COPD conditions (WHO, 2002). Genetic factors play a 
role in the propensity for certain individuals to contract COPD. This is mainly due to a 
deficiency in protease alpha1-antitrypsin (Janoff, 1983; Mannino and Buist, 2007; Stockley, 
Mannino and Barnes, 2009). Severity of the disease and the effects that acute 
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exacerbations have on the progression of the disease impact on the quality of life (QoL) of 
patients with COPD (Andenaes et al, 2006; Koblizek et al, 2009; Zhou et al, 2009; 
Motohashi et al, 2010). Dypsnoea, limited exercise tolerance, fatigue, associated 
cardiovascular disease, muscle wasting and weakness, osteoporosis, weight loss, 
depression, and anxiety are all factors which have a bearing on the QoL of patients with 
COPD (Lisboa et al, 2001; Nazir and Erbland, 2009). 
 
The anti-inflammatory role of exercise is addressed in the literature in relation to land-based 
exercise (Jankord and Jemiolo, 2004; Kasapis and Thompson, 2005). The link between 
chronic disease and inflammation is well documented (Zebrack and Anderson, 2002; 
Pedersen and Bruunsgaard, 2003; Pedersen and Pedersen, 2005). COPD is associated 
with pulmonary as well as systemic inflammation (Heaney, Lindsay and McGarvey, 2007; 
Papaioannou et al, 2009). The management of COPD by physiotherapists focuses mainly 
on land-based treatment methods. Lacasse et al (2009) reported on the effects of 
pulmonary rehabilitation (PR) on exercise capacity for patients with COPD and the changes 
in QoL related to health issues in this population. Their Cochrane systematic review 
demonstrated that pulmonary rehabilitation had a favourable impact on all parameters of 
QoL measured by the chronic respiratory questionnaire (CRQ) and the St George‟s 
respiratory questionnaire (SGRQ) for patients suffering from COPD. Exercise capacity, as 
measured through cycle ergometry, showed a positive weighted mean difference of 8.4 
watts between the rehabilitation groups and the control groups over the total number of 
studies appraised. The six-minute walk distance test (6MWD) test, utilised across 16 trials 
to evaluate functional exercise capacity, demonstrated a weighted mean difference of 48 
metres in distance walked between the rehabilitation and the control groups (Lacasse et 
al,2009). Langer et al (2009) showed that health-related quality of life (HRQoL) and 
functional exercise capacity was improved when a clinical practice guideline to treat 
patients with COPD was implemented.  
 
Immersion in water, in the form of hydrotherapy, has been utilised since the ancient Greek 
times of Hippocrates (460-377 BC) and the early Roman era (Papavramidou and 
Christopoulos-Aletra, 2003). Reports of aquatic exercise being utilised in the management 
of patients with chronic diseases have been recorded in the United States of America 
between 1840 and 1900. American President Franklin D Roosevelt found that the 
hydrotherapy he underwent between 1924 and 1927 relieved debilitating muscular spasms 
experienced as part of his poliomyelitis affliction (Sinclair, 2008). More recently beneficial 
effects of hydrotherapy on various chronic diseases have been reported. Hydrotherapy was 
used in the pre-operative management of patients undergoing total hip or knee 
replacements in order to reduce pain and improve function (Gill, McBurney and Schultz, 
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2009). In a review, looking at hydrotherapy treatment of a combination of hip and knee 
osteoarthritis, short term benefits were reported with small to moderate improvements 
noted in function and QoL  and minor improvements in pain levels (Bartels et al, 2007). In a 
review of information on the treatment of low back pain with hydrotherapy it was concluded 
that therapeutic aquatic exercise was potentially beneficial in this particular patient 
population (Waller, Lambeck and Daly, 2009). Elyan and Khan (2008) reviewed information 
on the use of water therapy in the treatment of patients with ankylosing spondylitis and 
reported that the symptoms of the disease, function and perception of health may be 
improved. Patients with rheumatoid arthritis demonstrated improvements in muscle 
endurance in both the upper and lower limbs when they performed moderately intensive 
exercise in warm water (Bilberg, Ahlmen and Mannerkopi, 2005). Hydrotherapy was used 
to treat pain in fibromyalgia with beneficial outcomes (Evcik et al, 2008). In a randomised 
controlled trial (RCT) conducted by Chu et al (2004) people with chronic stroke were given 
a water-based exercise programme. The primary outcome measured was cardiovascular 
fitness and the researchers concluded that this form of exercise regime, in hemiplegic 
patients, might be an effective way to promote fitness in that population.They also noted 
improvements in maximal workload, muscle strength, gait speed and the Borg balance 
scale score in the intervention group of stroke patients. Noh et al (2008) found 
improvements in postural balance and knee flexor muscle strength, after an aquatic 
intervention based on the Ai Chi and Halliwick hydrotherapy methods, in stroke survivors. 
Water therapy was used to aid recovery, after exercise, in athletes (Banfi and Melegati, 
2008) and was also used in an attempt to improve athletic ability (Hamlin, 2007). Dowzer et 
al (1999) examined the physiological effects of running in deep water and shallow water 
with a view to seeing whether the information could be extrapolated and applied to 
recovering athletes in order to maintain their cardiovascular fitness. They concluded that 
shallow water running (SWR) showed potential as a re-training strategy as SWR elicited 
higher peak oxygen uptake (VO2peak) levels and heart rate (HR) levels when compared to 
deep water running (DWR) results. They also remarked that it was easier to train in shallow 
water as there was no need for a flotation device and it was less threatening to patients 
who had a fear of water.   
 
Beneficial effects of hydrotherapy have also been reported in the elderly as well as in 
patients who suffer from chronic cardiac conditions. Ide, Belini and Caromano (2005) 
demonstrated an increase in inspiratory muscle strength with a water-based breathing 
programme in healthy, aged persons. In patients with chronic heart failure a regime of 
immersion, gymnastics and swimming led to an increase in cardiac index (Schmid et al, 
2007). An aquatic training, detraining and retraining regime in patients with coronary artery 
disease reported beneficial improvements in VO2peak, total body strength and stress test 
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time during the training and retraining phases (Tokmakidis, Spassis and Volaklis, 2008). In 
view of the reported beneficial effects of hydrotherapy treatment in the management of 
patients with various chronic diseases the researcher decided to investigate the role of 
hydrotherapy as a component of the PR of patients with COPD. 
 
1.2 STATEMENT OF PROBLEM AND JUSTIFICATION FOR RESEARCH 
With the increase in the incidence and prevalence of COPD worldwide, as reported in WHO 
documents and various other surveys, an emphasis has been placed on the search for new 
treatment options to address effective management strategies for these patients. 
Pulmonary rehabilitation (PR), in the form of land-based exercises, has been shown to play 
an important role in improving these patients‟ QoL by not only addressing their physical 
needs, but also providing them with interaction with health care professionals as well as 
other patients with COPD to facilitate the necessary psychological support. Patients with 
COPD have expressed boredom while doing the same land-based exercises repeatedly 
and therefore hydrotherapy may offer an interesting alternative exercise option to those 
patients (Perk, Perk and Bodén, 1996). Much has been written in the literature about 
cardio-pulmonary changes in healthy individuals, during immersion in water, relative to the 
effect of temperature and depth of the water on such outcomes and the different exercise 
modalities employed. It is not known whether much information has been documented on 
the effects of such interventions on the COPD population. A review of the available 
literature on the use of hydrotherapy for these patients will be a valuable tool in the 
investigation, analysis and reportage on the resultant effects of this intervention in the 
COPD population.   
 
1.3  RESEARCH QUESTION 
What is the role of hydrotherapy in the management of patients with COPD? 
 
1.4  SIGNIFICANCE OF RESEARCH 
The incidence of COPD is likely to remain high due to the worldwide prevalence of 
smoking. Compounding the African incidence of this disease is an human 
immunodeficiency virus/ acquired immunodeficiency syndrome (HIV/AIDS) pandemic that 
leads to tuberculosis and pneumocystis jerovecil pneumonia and predisposes patients to 
the development of COPD (Calderon et al, 1996; Probst et al, 2000; Morris et al, 2008) It is 
feasible to use the proven anti-inflammatory effects of exercise to counteract the 
inflammatory processes at work in patients suffering from COPD. Land-based exercise in 
the form of pulmonary rehabilitation programmes (centre-based and home-based) is 
demonstrated to be beneficial in the COPD population as improvements in QoL, levels of 
dyspnoea and participation in ADL have been widely reported. However, reported benefits 
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obtained through hydrotherapy in various patient populations include reduction in pain, 
increased inspiratory muscle strength and cardiac index as well as several musculoskeletal 
benefits. The effects of hydrotherapy on the cardiopulmonary and musculoskeletal systems 
of patients with COPD will be examined in this systematic review to see if hydrotherapy 
would be a useful additive to existing pulmonary rehabilitation programmes. It is intended 
that the results could be used by clinicians to set up practice guidelines for the use of 
aquatic exercise in patients with COPD. It is hoped that the review will assist the researcher 
to identify areas for future research in the field of rehabilitation of patients with COPD. 
 
1.5  RESEARCH AIM 
To systematically review the evidence related to the role of hydrotherapy in the 
management of patients with COPD. 
 
1.6  RESEARCH OBJECTIVES 
 To determine, from the literature, how water temperature and depth of immersion 
influences cardiopulmonary function in patients with COPD. 
 To determine, from the literature, if hydrotherapy increases endurance in patients with 
COPD. 
 To determine, from the literature, if hydrotherapy increases function in patients with 
COPD. 
 To determine, from the literature, if hydrotherapy increases the QoL of patients with 
COPD. 
 To determine, from the literature, whether the anti-inflammatory effects of water-based 
exercises in patients with COPD have been documented.  
 
1.7  TYPE OF STUDY 
A qualitative systematic review of the relevant literature was performed. 
 
Chapter 2 consists of an in-depth discussion of the literature on the development of COPD, 
its influence on endurance and function in ADL and its effects on QoL. The medical 
management of patients with COPD is discussed as well as current rehabilitation 
interventions used in this patient population. Hydrotherapy and its reported benefits in the 
management of other patient populations are discussed. 
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CHAPTER 2 
 
2. LITERATURE REVIEW 
This review aims to critically evaluate evidence found in the medical and rehabilitation 
literature about the processes involved in the development of COPD and its impact on the 
human body. It also evaluates the effects of COPD on endurance, function and QoL as well 
as benefits and risks reported for hydrotherapy in other patient populations. In addition it 
aims to provide the evidence to support research into this specific form of exercise in the 
rehabilitation of patients with COPD. 
 
2.1 FACTORS PREDISPOSING TO THE DEVELOPMENT OF COPD 
In a schematic view of lifestyle diseases that share similar risk factors (SAMRC, 2008) 
emphysema was named as a chronic disease of lifestyle and was linked to smoking.  
Statistics available showed the prevalence of smoking globally and linked it to the incidence 
of morbidity and mortality from lifestyle diseases (British Heart Foundation, 2008). In 2001, 
according to the WHO‟s global burden of disease and risk factors project, COPD ranked 
fifth as a leading cause of death in countries whose citizens were in an upper income 
bracket and sixth in those countries with citizens in a middle or lower income category. 
Furthermore COPD accounted for 3-8% of total deaths in the higher income group and 4-
9% of total deaths in the middle/lower income group (Mannino and Buist, 2007). 
 
 A greater prevalence of COPD was reported in countries where cigarette smoking was 
common (Pauwels et al, 2001). Bateman and Jithoo (2006) pointed out that the lung was 
more vulnerable to diseases of lifestyle than probably any other organ in the body. In the 
South African context they linked this fact to the increase in the prevalence of asthma and 
COPD caused by smoking. Considering the South African trends, as recorded in the 
SAHDS of 1998, it was noted, by Schneider et al (2009), that the poor were more exposed 
to noxious smoke from the fuel used in their homes and were more inclined to smoke than 
their wealthier counterparts. However, the richer members of society, smoked more 
cigarettes per capita than the poorer smokers (Schneider et al, 2009). Smoking has been 
described as the main risk factor for the development of COPD (Mannino et al, 2006; 
Stockley, Mannino and Barnes, 2009). Biochemical links have been shown to exist between 
the development of pulmonary emphysema and cigarette smoking with these changes 
being due to elastolytic activity in the lung connective tissue, acting in an unrestrained 
fashion and hence causing the breakdown in alveolar structure (Janoff, 1983). 
Environmental exposure to air pollution was linked to the development of COPD (Stockley, 
Mannino and Barnes, 2009) as was childhood exposure to lower respiratory tract infections 
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(Shaheen, Barker and Holgate, 1995). In non-smokers, particularly in developing countries, 
links have been established between the inhalation of smoke from the combustion of 
biomass fuels and the development of COPD (Salvi and Barnes, 2009). Increase in age 
reportedly leads to an increase in the prevalence, morbidity and mortality of the disease 
(Mannino and Buist, 2007). Genetic factors also play a role in the propensity for certain 
individuals to contract COPD. This was mainly due to a deficiency in the protease alpha1-
antitrypsin (Janoff, 1983; Mannino and Buist, 2007; Stockley, Mannino and Barnes, 2009). 
 
According to the WHO “Tobacco Atlas” (2002) the prevalence of smoking among males 
globally was found to be highest in China with 300 million smokers being recorded. This 
number equalled the entire population of the USA. In the Russian Federation and many of 
the satellite states which were incorporated in the former Soviet Union there was a reported 
incidence of smoking of 60% or more among males. On the African continent the highest 
incidence of smoking among males was in Namibia (50%), Kenya (49%) and Tunisia. The 
incidence of smoking among men in South Africa was reported to be 42%. Bosnia and 
Herzegovina and Guinea were shown to have the highest global incidence of smoking 
within their female populations (WHO, 2002). On the African continent the highest 
incidence of smoking among females was recorded in Guinea where between 40% and 
49% were smokers. In South Africa 11% of the female population were recorded as being 
smokers. The countries which showed an equal ratio of male smokers to female smokers 
were New Zealand, Norway and Sweden. Statistics showed that between 1960 and 2000 in 
the United Staes of America (USA), United Kingdom (UK) and Japan a gradual decrease in 
the percentage of smokers in both sexes was recorded (WHO, 2002). Nearly 25% of 
children who smoke started before the age of ten. In countries such as Ghana, Grenada, 
India, Jamaica and Poland over 30% of children fell into this category (WHO, 2002). It was 
reported that the earlier the age at which a person began to smoke the greater the risk 
would be for that person to contract smoking-related diseases in later life (WHO, 2002).    
 
The prevalence of passive smoking worldwide was such that 40% of children were exposed 
to it in their home environment as children are at particular risk from adult smoking habits. 
Pneumonia, bronchitis, coughing and wheezing, asthma attacks and cardiovascular 
disease can all result from such exposure (WHO, 2002) .The reasons that young people 
start to smoke are linked to tobacco advertising, availability of cigarettes and low prices 
which made smoking more appealing and accessible. Peer pressure from friends and 
family often persuaded the child, with a low self image, to begin smoking to raise their 
social profile. If the parents of children were smokers those children had an increased 
propensity to smoke (WHO, 2002). 
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In 1976 a research report by British American Tobacco (WHO 2002)) said that women were 
more highly motivated to smoke than their male counterparts and therefore they were less 
likely to quit smoking. The liberated, slim, sophisticated and modern woman was what the 
tobacco industry falsely associated with the image of the female smoker in order to entice 
young women to begin smoking. In the case of male smokers the lure of smoking was 
probably due to the portrayal of smokers as being manly, masculine, and wealthy, with 
increased sexual prowess, health and happiness. The reality was debilitating diseases such 
as atherosclerosis, cardiac disease, COPD, osteoporosis and anaemia as well as the 
resultant complications and symptoms of such diseases; stroke, hypertension, dyspnoea, 
fatigue, decreased exercise capacity, fractures and general decline in the ability to perform  
ADL and therefore a decreased QoL (WHO,2002). During pregnancy exposure to cigarette 
smoke was reported to harm the foetus (Ahluwalia, Grummer-Strawn and Scanlon, 1997).  
In female smokers there was also the risk of babies with a low birth weight and the resultant 
complications (Dejmek et al, 2002). There was also a proven link between mothers who 
smoked and babies who suffered from sudden infant death syndrome (SIDS) (Dejmek et al, 
2002).  
 
Smoking is one of the most difficult addictions to overcome. According to the WHO 
“Tobacco Atlas” (2002) the worldwide incidence of those who manage to quit smoking was 
not very high. The highest percentage of people to quit smoking by 2002 was in Zambia 
(72%). However, this statistic did not reflect the global trend where the next best 
percentage for quitting was 42% in the USA. The other recorded values lie in the range 
between 1% and 40%. Fortunately, in many developed countries (USA, UK, Australia and 
Canada) smoking among women was on the decline. However, there was a stagnation or 
increase in smoking among women in southern, eastern and central European countries. 
 
Many different forms of cessation aids to enable the smoker to quit have been marketed 
over the years. Among these are nicotine-based chewing gums, nicotine-based „patches‟, 
cigarette filters which remove a good deal of the noxious gaseous components of the 
cigarette smoke  and more recently a smokeless electric cigarette which delivers a certain 
quantity of nicotine and fulfills the smoker‟s need to have a cigarette to hold and „smoke‟. In 
the case of the electronic cigarette the nicotine „dosage‟ is decreased gradually.  
Hypnotherapy and motivational methodologies are also applied to enable the smoker to 
quit. However, the fact still remains that for a smoker to quit successfully they have to use 
their own willpower to overcome the craving.  
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2.1.1  The Role of Cellular Mediators in the Development of COPD 
Various authors define COPD as a disease characterised by non-reversible progressive 
airflow limitation with chronic inflammatory changes as a result of exposure to noxious 
particles and gases (Pauwels et al, 2001; Barnes 2003). Shapiro (1999) investigated the 
role of the macrophage in COPD. He described the inflammatory cell recruitment in the 
lung tissue which was initiated by chronic cigarette smoking and resulted in more than five 
times the number of total cells present during bronchoalveolar lavage (BAL). He reported 
that 95%-98% of these cells were macrophages and that the elastolytic proteases released 
by these inflammatory cells destroyed the lung parenchyma, a fact verified by Russell et al 
(2002). Neutrophils, acting alone or together with alveolar macrophages, produced an 
increase in protease production (Barnes, 2003). Di Stefano et al (1998) found that there 
was a correlation between the number of neutrophils in sputum and the degree of severity 
of the COPD. In patients with emphysema, macrophages were found in the alveolar wall 
where destruction of tissue was observed (Finkelstein et al, 1995; Meshi et al, 2002). It was 
hypothesised that the release of inflammatory mediators, such as interleukin-8 (IL-8), TNF-
alpha, leukotriene B4 (LTB4) and reactive oxygen species, by macrophages stimulated by 
cigarette smoke, highlighted the link between cigarette smoking and inflammation in COPD 
(Barnes,2003). Keatings et al (1996) did a study in which they induced sputum production 
in 16 non- smoking control subjects, 23 patients with asthma, 12 healthy cigarette smokers 
and 14 patients with COPD. The researchers concluded that there was evidence to 
perhaps substantiate the fact that TNF-alpha and IL-8 played a role in the inflammatory 
processes seen in COPD. Other researchers reported that it was possible that T- 
lymphocytes played an active role in the pathological changes towards emphysema seen in 
smokers (Finkelstein et al, 1995; O‟Donnell et al, 2005). The combination of cigarette 
smoke medium (CSM) and TNF-alpha at below threshold levels seemed to increase IL-8 
production greatly, a factor not realised when either of these two agents were present alone 
(Sarir et al, 2009). Citing the work done by Finkelstein et al (1995) and O‟Shaughnessy et 
al (1997), Barnes (2003) reported that, within the T-lymphocyte cellular category, CD8+ T-
cells showed the most prolific increase in numbers in the lung parenchyma and central and 
peripheral airways of patients with COPD. There was a positive correlation found between 
the extent of alveolar destruction and the limitation of airflow due to obstruction and the 
number of T-cells.   
 
Saetta et al (1993) showed that, in patients with chronic bronchitis, there was a significant 
increase in T-lymphocytes and macrophages found in the bronchial mucosa. These 
researchers noted that, in the case of chronic bronchitis, it was the central airways that 
were inflamed. MacNee (2005) reported on the findings of a study carried out by Hogg 
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(2004) in which that researcher had stated that the inflammation, in the case of chronic 
bronchitis, was in the central airway epithelium and also in the mucus-producing glands. 
Hogg (2004) linked mucus hypersecretion to the inflammatory processes. MacNee (2005), 
by way of debate on this matter, reported on work done by Vestbo and Lange (2002),and 
noted that those authors had concluded that early manifestations of mucus hypersecretion 
and its link to limitation of airflow in COPD was uncertain. Vestbo and Lange (2002) also 
concluded that, due to the fact that smokers with normal lung function but with increased 
mucus production do not necessarily develop COPD later in life, mucus hypersecretion 
appeared to contribute little to the inflammatory processes in the early stages of COPD. 
MacNee (2005), reporting on a study by Fletcher and Peto (1977), further noted that in the 
later stages of the disease exacerbations linked to mucus hypersecretion may lead to 
decreased FEV1 levels and may be a result of the inflammatory response in the 
submucosal glands. Hence it appears that MacNee (2005) agreed with the link established 
by Hogg (2004) between mucus hypersecretion and the inflammatory processes seen in 
COPD. However, MacNee (2005), after reviewing the work done by Fletcher and Peto 
(1977), suggested that the inflammatory processes were seen in the later stages of COPD. 
Saetta et al (1996) showed that, in exacerbations of chronic bronchitis, there was a similar 
eosinophil expression as in asthma. However, they found an increased amount of 
interleukin-5 (IL-5) protein in the bronchial mucosa of the asthmatics which was not present 
in the patients with chronic bronchitis. Inflammation in asthma was mainly eosinophilic and 
was driven by CD4+ lymphocytes (WHO, GOLD global initiative for COPD, 2005; O‟Donnell 
et al, 2005). 
 
Gan et al (2004) undertook a systematic review and meta-analysis to establish the 
relationship between COPD and systemic inflammation. The authors concluded that C-
reactive protein, leukocytes, fibrinogen and TNF-alpha levels were raised in individuals with 
obstructed airflow. In the case of ex-smokers there was still a degree of low grade systemic 
inflammation detected. These researchers noted that, in the articles under review, there 
was mention of a link between systemic inflammation and complications such as 
osteoporosis (Biskobing, 2002; Agusti et al, 2003), loss of body weight (Di Francia et al, 
1994; de Godoy et al, 1996; Eid et al, 2001), pulmonary cachexia (Schols, 2002; Agusti et 
al, 2003) and cardiovascular disease (Friedman, Klatsky and Siegelaub, 1976; Hole et al, 
1996; Schünemann et al, 2000). In a review of studies looking at the possible origins of 
systemic inflammation in COPD Wouters (2005) cited work done by; Dietrich et al (2002) 
and Dietrich et al (2003) who reported that, in passive smokers and those with only a few 
pack years, dysfunction was found in the peripheral vascular endothelium and systemic 
oxidative stress was recorded; Vernooy et al (2002) looked at the possible role of local 
pulmonary inflammatory response in the creation of a systemic inflammatory response; 
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Michel et al (2001) showed that the systemic inflammatory response was independent of 
that in the pulmonary compartment ; it was suggested that hypoxia was a possible reason 
for the activation of the TNF system and to this end Takabatake et al (2000) found a 
significant correlation between the prevalence of TNF- alpha in the peripheral circulation 
and hypoxia in the tissues. One of the key inflammatory indicators found in COPD was C-
reactive protein (Vestbo, 2007). He also reported that there was a link between the 
systemic co-morbidities associated with COPD and systemic inflammation. Cytokines 
recruited, activated and promoted the ongoing multiplication of inflammatory cells 
throughout the respiratory tissue (Barnes, 2008).  
 
Therefore in summary, links have been firmly established between smoking and the 
production of cells which promote inflammatory processes resulting in destruction of lung 
parenchyma in patients with COPD. When acting alone, or in combination, macrophages 
and neutrophils promote the release of electrolytic proteases which destroy the tissue of the 
lung. Macrophages have also been linked to the release of inflammatory mediators TNF-
αlpha, IL-8, LTB4 and reactive oxygen species when stimulated by cigarette smoke. 
Furthermore, CSM in combination with below threshold levels of TNF-alpha seems to 
increase the levels of IL-8 greatly. T-lymphocytes, and in particular CD8+ T-cells, showed 
prolific increases in numbers in patients with COPD and contribute to the pathological 
changes towards emphysema in smokers. Systemic inflammation, found in patients with 
COPD, was linked to raised C-reactive protein, leukocytes, fibrinogen and TNF-alpha 
levels.  A degree of low grade systemic inflammation was seen in ex-smokers. 
 
2.2  CLASSIFICATION OF SEVERITY OF COPD 
The GOLD classification of severity of COPD (GOLD,2005) states the following: Stage 0 
denotes those patients at risk of developing the disease who exhibit a productive cough 
and presents with normal spirometry; Stage 1 is classified as mild COPD with FEV1 ≥ 80% 
predicted; Stage 2 is moderate COPD with 50% ≤ FEV1< 80% predicted; Stage 3  is severe 
COPD with 30%≤ FEV1 < 50% predicted and Stage 4 is very severe COPD with FEV1< 
30% predicted or FEV1< 50% predicted with chronic respiratory failure. Bateman et al 
(2004), in a guideline for the management of COPD in South Africa, linked the stages of 
severity to dyspnoea and functional impairment. According to these authors Stage 0 is 
related to normal exercise tolerance; patients with Stage 1 experience limitations with 
strenuous activity; those with Stage 2 manage limited activities done at a normal rate and 
those with Stage 3 have a compromised lifestyle with their ADL seriously affected and/or a 
completely sedentary lifestyle. With regard to performance on the 6MWD test, the distances 
that patients would manage to walk were as follows: Stage 0 >600 m (normal result); 
Stages 1 and 2 <600 m-200 m andStage 3 <200 m. Measures of severity reflect the 
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progressive nature of the disease and the impact it has on the lifestyle impairment of the 
patient. 
 
The multi-factorial prognostic index (BODE) which comprises measures of body mass 
index, airflow obstruction, dyspnoea and exercise capacity was described in a study which 
compared it to the GOLD classification for the parameters of anxiety and depression in 
patients with COPD (Funk et al, 2009). The researchers found that the prevelance of 
anxious symptoms, linked to dyspnoea, increased with the BODE stages of severity of 
disease but did not increase with the GOLD classification of the stages of COPD. However, 
with symptoms of depression, explained by both dyspnoea and exercise capacity, the 
increase shown related to both the GOLD and the BODE scales. The researchers 
concluded that the BODE index was a better measure than the GOLD classification for 
explaining depressive and anxious symptoms in patients with COPD (Funk et al, 2009).   
 
2.3 THE INFLUENCE OF COPD ON ENDURANCE AND FUNCTION IN ACTIVITIES OF 
DAILY LIVING 
 
Skumlien et al (2006) looked at gender differences, in patients with COPD, in relation to 
ADL. They used the Pulmonary Functional Status and Dyspnoea Questionnaire (PFSDQ) 
to measure dyspnoea during ADL, general dyspnoea and loss of performance related to 
function. They reported that the ability to perform ADL was limited by COPD a fact 
confirmed by Lahaije et al (2010). Skumlien et al (2006) also noted that dyspnoea scores 
were not influenced by gender differences and that the PFSDQ could be used to measure 
outcomes accurately in both females and males. They emphasised that the loss of 
functional performance in females, in relation to household management, had to be 
considered when designing an effective treatment programme for female patients with 
COPD. 
 
Garrod et al (2000) stated that the assessment of the level of restriction of ADL in patients 
with COPD had to report on the impact of the handicap and disability on the ADL. One of 
the first measures of dyspnoea, developed in association with the Medical Research 
Council (MRC) Committee on the aetiology of chronic bronchitis, was the Fletcher (MRC) 
dyspnoea scale (Fletcher, 1960). Dyspnoea and fatigue associated with COPD have led to 
functional limitation and disability (Pitta et al, 2006). In fact, dyspnoea in patients with 
COPD was frequently reported in the performance of everyday tasks (Restrick et al, 1993; 
Bestall et al, 1999). Patients with COPD are far more handicapped in relation to their ability 
to lead an active life than healthy elderly people (Pitta et al, 2005). The increasingly poorer 
performance of ADL by patients with COPD was linked to the deterioration in health of 
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these individuals and the decrease in related exercise capacity (Oga et al, 2005). Pitta et al 
(2005) looked at a comparison of physical activities in the daily lives of patients with COPD 
(GOLD classification 2 –4) and healthy individuals in a similar age group. The physical 
activities assessed included walking, cycling, standing and sitting. They concluded that 
most patients with COPD spent more time lying down or sitting than walking or standing in 
daily life. These researchers also noted that the gait of patients with COPD was significantly 
slower than that of healthy individuals with a lower movement intensity displayed. The 
authors found that the 6MWD test provided an accurate measurement of the difference in 
performance between the two groups. It was noted by the researchers that the healthy 
individuals and patients with COPD who walked more in daily life walked further during the 
6MWD test.The mean percentage predicted distance walked by the COPD group was 62 ± 
22m and that by the healthy group a significant 98 ± 10m. Sixteen out of 20 patients with 
COPD, who walked less than 400m, had an average daily walking time of less than 30 
minutes.The authors concluded that patients who performed poorly on the 6MWD test were 
likely to undertake very little physical activity in daily life.  
 
Many methodologies and tools have been developed in order to assess different 
parameters related to the measurement of the ability of patients with COPD to perform 
ADL. The American Thoracic Society (ATS) issued guidelines in 2002 for the utilisation of 
the 6MWD test. It was suggested that the test could be used to assess the effect of a 
course of pulmonary rehabilitation on exercise endurance when measurements were taken 
pre and then post treatment. Schönhofer et al (1997) looked at the role of a pedometer as a 
repeatable measure of evaluating daily activity in patients with COPD. They concluded that 
such an intervention could be used in conjunction with a questionnaire in order to assess 
exercise limitation caused by COPD. Van Helvoort et al (2007) conducted a study in which 
they evaluated the effect of a 6MWD test on patients with COPD with muscle- wasting. 
Oxidative stress and systemic inflammation were shown to play a part in the systemic 
immunological response which the authors found to be comparable to that of a maximal 
cardiopulmonary exercise testing response. They showed a possible interaction between 
oxidative stress, systemic inflammation and the degree of muscle wasting in patients with 
COPD and the effect these factors had on ADL. Borel et al (2010) developed the six minute 
stepper test (6MST) as an alternative to the 6MWD test and suggested it could be used 
effectively to evaluate exercise tolerance in patients with COPD. It also negated the 
necessity for a passage of a specific length to have to be used to calculate the data as the 
stepper took up very little space. 
 
Lacasse et al (2009) highlighted the importance of the demonstration of physiological 
rationale behind programmes of exercise training in patients with COPD in order to 
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accurately measure rate of perceived exertion (RPE) and to reproduce these results for 
comparative purposes. The scale most widely used to assess RPE was the Borg scale (first 
developed by Borg and Lindblad in 1976). The original scale consisted of 15 grades 
ranging from 6 to 20 with the configuration being chosen to best match heart rates ranging 
from 60-200 beats per min-1. However, age, type of exercise, anxiety, environment and 
other factors influenced the outcomes. The modified Borg scale was constructed as a 
category scale with ratio properties and ranged between 0 to10 with 0 being nothing at all 
and 10 being almost maximal exertion (Borg, 1982).  
 
Dyspnoea was defined by the ATS (1999) as” a subjective experience of breathing 
discomfort that consisted of qualitatively distinct sensations that varied in intensity.” The 
experience of shortness of breath is a multi-factorial one which resulted from numerous 
psychological, physiological, environmental and social factors acting together to produce 
resultant behavioural and physiological reactions (Hill et al, 2004). Borg was also 
instrumental in the development of a dyspnoea -rating scale (Borg, 1982). Another 
measurement tool, used to measure the intensity of dyspnoea, is the visual analogue scale 
(VAS). Von Leupoldt et al (2006) compared the VAS scale to the Borg scale in a study 
looking at the sensory and affective aspects of dyspnoea. Their results demonstrated that 
the Borg scale was influenced differently by sensory and affective aspects of dyspnoea and 
hence they concluded that different scales should be considered in the evaluation of the 
perception and reporting of dyspnoea. Mahler and Horowitz (1994) evaluated these tools in 
their study and found them to produce valid, responsive and reliable measurements of 
dyspnoea and efficacy of therapy.  
 
Bestall et al (1999) demonstrated the validity of the MRC dyspnoea scale as a valid means 
of dividing patients with COPD into categories according to their disability rating and 
according to the level of severity of their disease. Tangri and Woolf (1973) postulated that it 
was unlikely that the degree of dyspnoea witnessed in a patient with COPD after a simple 
ADL like brushing teeth was due to the minor exertion involved. They therefore looked at 
breathing patterns in patients with COPD and concluded that they were different from those 
seen in normal control subjects. The main difference seen was that, whereas the patients 
with COPD had to hyperventilate to normalise blood gas levels post-activity, the healthy 
group only needed a few deep breaths to achieve the same result. In a study which was 
prompted by patients with COPD complaining of tiredness and dyspnoea Velloso et al 
(2003) looked at four ADL, which involved the use of the upper limbs and thoracic muscles, 
with respect to ventilatory and metabolic outcomes in patients with COPD. The activities 
were associated with a high energy demand and consisted of erasing a blackboard, 
replacing lamps, sweeping and lifting pots. The performance of the four activities increased 
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the oxygen uptake (VO2) demands in the patients and the researchers suggested this was 
possibly the reason why the patients felt tired during the execution of these easy tasks 
involving the upper limbs. 
 
Garrod et al (2000) developed the London chest activity of daily living scale (LCADL) in 
order to validate a standardised measure of ADL in patients with severe COPD. They 
compared the results obtained with their questionnaire with the activity and impact 
components of the SGRQ (Jones, Quirk and Baveystock, 1991) and the Nottingham 
extended activity of daily living questionnaire (NEADL) and found good correlations with 
both of these. This study highlighted the fact that carers and relatives were necessary to 
assist patients with severe COPD in their ADL. Disability was marked in the case of self-
care items like getting dressed, drying after a bath, putting shoes and socks on and 
washing hair. Assistance was needed with activities like cleaning a floor or washing 
curtains. The COPD activity rating scale (CARS) was developed by Morimoto et al (2003). 
Their results suggested that the scale was a valid tool to use when assessing ADL in 
patients with COPD. Pitta et al (2006) compared and discussed the use and effectiveness 
of questionnaires and motion detector devices in the accurate assessment of performance 
in ADL and functional capabilities in patients with COPD.They found the motion detector 
type of recording device to be of more value. 
 
Hence, from the above information it can be concluded that COPD has been shown to limit 
the performance of ADL in patients who are suffering from this disease. The severity of 
COPD correlates directly with a reduction in exercise capacity and patients with COPD are 
more likely to follow a sedentary lifestyle. Dyspnoea and fatigue lead to functional limitation 
and disability. Disability related to self-care matters can be marked and often necessitates 
the involvement of carers and relatives to assist the patient with such matters. Many 
measurement tools are available to assess the level of disability related to the performance 
of functional activities and the limiting factors associated with the ability to perform the ADL. 
Gender related differences should be considered when drawing up a treatment programme 
for patients with COPD.  
 
2.4  THE INFLUENCE OF COPD ON QUALITY OF LIFE 
The term QoL was described by Engstrőm et al (1996) as an indication of a patient with 
COPD‟s mental and physical well-being in relation to the severity of their disease. These 
researchers compared results from a COPD population and a control group in relation to 
their performance on the Sickness Impact Profile (SIP), the Hospital Anxiety and 
Depression scale (HAD) and the Mood Adjective Check List (MACL). They looked at how 
the results obtained related to pulmonary function, dyspnoea, mental factors and the 
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indications of the severity of the disease as well as the correlation between the results and 
smoking habits. The SIP was used to determine the functional status of the patients.They 
concluded that, in the early stages of the disease patients were able to use coping 
mechanisms and possibly reserve pulmonary capacity in order to counteract any loss of 
pulmonary function and hence the generic questionnaires relating to QoL did not ascertain 
a significant deterioration in this regard. However, in the later stages of the disease, generic 
questionnaires could be used to discern changes in QoL in patients with different levels of 
pulmonary dysfunction. Smoking habits were not found to impact on a feeling of well-being. 
The authors also noted that clinical parameters may not adequately address the specific 
problems encountered by the individual patient. The SIP is usually regarded as a sickness-
related measure however, Engstrőm et al (2001), viewed it as a generic self-assessment 
questionnaire used to compare important functional aspects between diseases. In this 
particular application they suggested it was a valuable tool to accurately assess patient-
specific problems in order to utilise that information to draw up individualised rehabilitation 
programmes and assess treatment effect. Curtis, Deyo and Hudson (1994) and Kaplan and 
Reis (2007) stated that the term QoL was strongly linked to factors other than those 
dictated by the health of the patients. These included socio-economic factors (financial 
status, housing, employment and social support) and functional status. They also felt that, 
because many of the COPD patients were elderly HRQoL was a more fitting terminology 
when looking at the well-being of this category of patients.  
 
The ATS statement (1995), as reported by Ferrer et al (1997) on the diagnosis and care of 
patients with COPD stated that Stage 1 COPD minimally affected QoL but stages 2 and 3 
were linked to great deterioration in QoL. Ware and Sherbourne (1992) reported that 
HRQoL in COPD was better delineated by using the SGRQ and the medical outcomes 
short-form 36-item (SF-36) questionnaire than by the ATS‟s recorded stages of the disease. 
Lisboa et al (2001) linked the severity of impairment in HRQoL, in patients with COPD, to 
dyspnoea, muscle wasting, the inability to exercise and fatigue. The level of dyspnoea 
found in patients with COPD was thought to be a useful indication of HRQoL of these 
patients (Hajiro et al, 1999). Psychological factors such as anxiety and depression were 
also found to affect the HRQoL of patients with COPD (Lisboa et al, 2001). Ferrer et al 
(1997) showed that patients with mild COPD had a compromised HRQoL. They also linked 
the HRQoL to co-morbid disease processes. Verrill et al (2005) looked at how short-term 
and long-term pulmonary rehabilitation (PR) impacted on QoL. They used the SF-36 
questionnaire and the Ferrans and Powers quality of life index-pulmonary version III (QLI) 
to assess the effects of PR programmes of different duration on the QoL of patients with 
COPD. They concluded that QoL measures had improved after 12 weeks of PR 
participation and these improvements were maintained by 24 weeks of PR participation. 
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Hassanein and Narsavage (2009) found that physical and mental QoL, in patients with 
COPD, improved clinically after a PR programme of 90 minutes a day for two to three days 
per week over a maximum duration of three months (24 sessions) and that optimal 
beneficial  outcomes were related to greater patient compliance with the supervised PR 
programme. Motohashi et al (2010) showed, with the aid of high-resolution computed 
tomography (HRCT), that it was the severity of emphysema that was associated with 
HRQoL and generic QoL due to a reduction in diffusion capacity. They suggested that, in 
clinical practice, HRCT could be useful as a diagnostic tool for use in the elderly patient 
who was unable to undergo spirometry.              
 
The measurement of the QoL of patients with COPD is subjective. Among the many 
methods of assessment are: the SGRQ (Jones, Quirk and Baveystock, 1991), the CRQ 
(Morgan, 1991; Yohannes et al, 1998), the breathing problems questionnaire (BPQ) and 
the brief assessment of depression cards (BASDEC) for a measure of psychological well-
being (Yohannes et al, 1998). The SGRQ was described as a disease-specific health 
measure by Okubadejo, Jones and Wedzicha (1996). They reported that the relationship 
between hypoxaemia and the well-being of the patient with COPD was better established 
through the use of the SGRQ than with the SIP and the quality of well-being (QWB) scales. 
The SIP was originally developed by Gilson et al (1975) as a health status index and 
changes from one application to another were meant to provide indications of changes in 
health in the population being studied. Blinderman et al (2009) used the SIP scale as part 
of a multi-variate analysis to assess sickness-related impairment across 68 items 
catagorised into social behaviour, somatic autonomy, mobility control, social behaviour and 
feelings, mobility psychological autonomy and communication. 
 
Kaplan (2005) looked at three published studies of patients with COPD where data were 
collected and evaluated before and after PR using the QWB scale in order to establish the 
minimally clinically important difference (MCID). He reported that all three evaluations of PR 
showed changes on the QWB scale in excess of the predicted MCID value and he 
concluded that utility-based QoL measures provide data which could be easily interpreted 
and the methodology was sensitive enough to suggest beneficial effects of such 
rehabilitation in patients with COPD. In a study done in the USA which looked at HRQoL 
indexes from the National Health Measurement study the QWB self-administered scale was 
used as a measure of HRQoL in older US adults along with five other HRQoL 
measurement tools. The six scales showed similar patterns in age-related HRQoL by 
gender but the trends relating to HRQoL in the different population norms were similar but 
not identical.The QWB scale was comparable in its detection of the trends under review 
(Fryback et al, 2007).   
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Guyatt et al (1987) were responsible for the development of the CRQ which determined the 
effect of treatment on QoL in clinical trials. The finalised CRQ examined four aspects of the 
lives of patients; dyspnoea, fatigue, emotional function and mastery. The latter involved the 
patient‟s ability to deal with the disease and its effects. Morgan (1991) utilised the CRQ in 
his study in order to measure QoL in patients with chronic lung disease. He reported that he 
found the test of particular value in showing changes in disability with respect to elderly 
patients with COPD. In a very recent study Reda et al (2010) looked at the reliability of the 
chronic respiratory questionnaire self-reported (CRQ-SR) and the clinical COPD 
questionnaire (CCQ). These researchers concluded that both the CCQ and the CRQ-SR 
were equally valid and reliable but over the longer term (when the follow-up exceeds 26 
weeks) the responsiveness of the CCQ was better in the assessment of QoL factors in 
patients with mild to moderate COPD. 
 
The deterioration in the QoL of patients with COPD is linked to the systemic inflammatory 
processes associated with COPD and co-morbid conditions (Gan et al, 2004). As a patient 
with COPD is likely to suffer from a range of physical and psychological manifestations of 
the disease Nazir and Erbland (2009) recommended that a multi-disciplinary approach to 
the management of these patients would be advisable to help them attain a better overall 
QoL. Fan et al (2002) found that the lower the QoL rating of patients with COPD the higher 
the likelihood would be for them to need hospitalisation or to die from their condition. 
 
2.5  MEDICAL MANAGEMENT OF PATIENTS WITH COPD 
Bateman et al (2004) formed a working group that compiled a guideline for the 
management of patients with COPD on behalf of the South African Thoracic Society 
(SATS). The guideline suggested that, before treatment was started, confirmation of 
diagnosis and the stage of severity of the disease had to be determined by means of 
spirometry. Based on the severity of the disease, any symptoms of dyspnoea and airflow 
obstruction are treated. Rehabilitation and education were implicated as important non-
pharmacological interventions in the management of these patients. The guideline stated 
the importance of prevention of exacerbations and prompt treatment if exacerbations did 
occur. Any co-morbid complications had to be treated and great emphasis was placed on 
education on cessation of smoking. Similarly, Calverley et al (2007) and Gold (2009) state 
that treatment for COPD should be focussed on relieving symptoms, decreasing risk 
factors, preventing exacerbations and reducing mortality. 
 
Short -acting β2-antagonist (inhalers) or anticholinergic bronchodilators (inhalers), either 
alone or in combination, are suggested for use in Stage 1 disease (Bateman et al, 2004; 
Heaney, Lindsay and McGarvey, 2007). Another option mentioned is oral theophylline in a 
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sustained release form (Gold, 2009). In stage 2 disease regular use of short acting or long -
acting bronchodilators alone or in combination with oral theophylline is recommended 
(Bateman et al, 2004). With increasing severity of disease two or three of these drugs in 
combination is advocated. Formoterol and salmeterol are the recommended β2-antagonists 
and it is suggested that long-acting anticholinergic tiotropium should also be used (Heaney, 
Lindsay and McGarvey, 2007; Gold, 2009). If FEV1 is below 50% predicted, oral or inhaled 
corticosteroid for a trial period is indicated. With three or more exacerbations in a year or if 
the trial treatment proved effective a maintenance dosage of inhaled corticosteroids or a 
low-dosage of oral corticosteroid treatment is  deemed effective as a maintenance measure  
(Bateman et al, 2004).  In an editorial which looked at pharmacological interventions to 
reduce inflammation in COPD, Barnes (2007) cited a study by Bourbeau et al (2007) which 
reported on the anti-inflammatory effects in the airways of patients with FEV1≥ 25% 
predicted (post-bronchodilator) from salmeterol/fluticasone propionate. They concluded that 
a combined therapy using a long-acting β2 agonist together with an inhaled corticosteroid 
(ICS) was beneficial and had more effect on inflammation than the sole use of inhaled 
corticosteroids. Calverey et al (2007) looked at the same combination therapy in relation to 
spirometric values, frequency of exacerbations, health status and survival rates in patients 
with COPD. They concluded that the level of statistical significance attained, with regard to 
a reduction in death in the patients with COPD, was not equal to the predetermined level 
set. However, all other outcomes measured in these patients showed significant benefits. 
While ICS was shown to potentially reduce the risk of lung cancer in patients (Parimon et 
al, 2006) the TOwards a Revolution in COPD Health (TORCH) study (Crim et al, 2009) 
found that ICS alone or in a combination therapy could possibly be linked to the 
development of pneumonia in patients with COPD. Postma and Calverley (2009) concluded 
that the use of ICS, either alone or in combination with long-acting β2-antagonists (LABA) 
had beneficial outcomes in patients with moderate to severe COPD.  In contrast Suissa and 
Barnes (2009) put forward the case against the use of ICS in the treatment of COPD. They 
pointed out the RCTs conducted to investigate the validity of the use of ICS had not 
reported any real value in that form of treatment until the ICS treatment was used in 
combination with a LABA.  
       
2.6  REHABILITATION INTERVENTIONS FOR COPD 
NIci et al (2006) reported that, according to the American Thoracic Society/ European 
Respiratory Society (ATS/ERS) statement of 2006, PR is defined as “an evidence-based 
multidisciplinary and comprehensive intervention for patients with chronic respiratory 
disease who are symptomatic and often have decreased daily life activities.” Ries (2008) 
supported this definition and recommended that a tailor-made PR management plan should 
be drawn up for each patient. A multi-disciplinary approach was proposed in order to 
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address the physical, social and psychological aspects of the patients‟s requirements. The 
American College of chest physicians (ACCP) and the American association of 
cardiovascular and pulmonary rehabilitation (AACVPR), recently updated their original 
guidelines for PR and made new recommendations for outcomes from comprehensive PR 
programmes (Ries et al 2007). These recommendations, as outlined in a graphic in 
appendix A, included the use of exercise training of adequate duration and type and which 
was timed for maximal effect.  The authors recommended that exercise programmes be 
designed for the lower extremity, upper extremity and inspiratory muscles and geared 
towards improving the patient‟s ability to cope with ADL.The use of anabolic drugs was 
mentioned and treatment of co-morbid conditions was recommended.  Education about the 
disease and supplementation in the form of oxygen, nutrition and non-invasive ventilation 
was highlighted. Health care costs, utilisation of resources and future research also had to 
be taken into consideration.  
 
2.6.1 Pulmonary Rehabilitation for Patients with COPD 
Only two Cochrane reviews could be sourced on the topic of pulmonary rehabilitation in 
patients with COPD. Lacasse et al (2009) reported on changes in QoL shown in the studies 
they included in their review. They reported on results obtained with CRQ and SGRQ 
measurement tools and showed that PR was favoured overall when compared to normal 
community care. These authors reported on maximal exercise capacity where 
measurement was done using cycle ergometry. They showed that the weighted mean 
difference in performances between the intervention groups and the controls, over 18 
reviewed trials, was an increase of 8.4 watts. In the case of functional exercise capacity the 
authors reported a weighted mean difference in distance walked of 48m between the 
controls and the intervention group on the 6MWD test. However, the authors did state that 
the clinical significance of this result was questionable. Overall the authors of this review 
concluded that PR exhibited beneficial outcomes in the QoL domains and improved the 
patients‟ emotional outlook and mastery of their disease. In a Cochrane review Puhan et al 
(2009) looked at the effect of PR after exacerbation of COPD but did not state a definitive 
timing for the PR intervention after the exacerbation. However, they did mention that it 
would be during the recovery period. They reported that three of the six reviewed studies 
showed a significant decrease in numbers of patient re-admissions to hospital and a 
decrease in the need to treat numbers (NNT) in association with rehabilitation. QoL was 
greatly improved across all four domains of the CRQ and in the activity limited domains and 
total score measured by the SGRQ. Exercise capacity was increased from 60-215 m in the 
6MWD test and shuttle walk tests. A significant decrease in mortality was also noted. The 
vast improvement in the outcomes measured, post exacerbation, was attributed to the 
resultant improvememt during PR after the deterioration experienced by the patient during 
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the exacerbation and a possible modification of patient behaviour due to the chance to 
educate the patient and implement a home exercise programme (Puhan et al,2009). Puhan 
et al (2009) point out that the interpretation of the results obtained in their review could 
possibly be limited by the small size of the trials under consideration. 
 
A comprehensive and multi-disciplinary approach to PR is seen as the cornerstone of 
effective management of COPD in order to improve QoL and exercise capacity (Spruit and 
Wouters, 2007). Troosters et al (2010) stated that PR was instrumental in improving QoL, 
symptoms of exercise tolerance and reducing the chance of an exacerbation in patients 
with COPD. Exercise training, focussed on muscle dysfunction as a systematic 
consequence of COPD, improved joint mobility especially when linked to walking. Physical 
well-being and possible decrease of the perception of dyspnoea experienced by these 
patients was also noted (Rochester, 2003; Troosters et al, 2010). The use of lower limb 
exercise was recommended as a mandatory component of a rehabilitation programme 
(Ries et al, 2007). These researchers also stated that such exercise performed at higher 
intensity would result in greater physiological benefits than similar exercise performed at a 
lower intensity. Rochester (2003) concluded that both high and low intensity training was 
beneficial in improving exercise endurance even in patients with severe COPD. Patients 
with COPD walked less than their healthy counterparts. Lower limb activity played a large 
role in ADL. An objective and subjective assessment of activity after rehabilitation showed 
an improvement (Walker et al, 2008). Man et al (2009) focussed their review on the effects 
of PR on the quadriceps muscle in patients with COPD. They concluded that clinically PR 
resulted in an increase in muscle strength and endurance, reduced the fatigability of the 
muscles and resulted in a small increase in fat-free muscle mass and cross-sectional area 
(CSA) of the mid-thigh region. Structurally they concluded that a) fibre-type proportions 
showed no significant changes, b) there was an increase in muscle fibres in the CSA under 
examination and c) each muscle fibre type had increased access to the capillary network. 
There were also metabolic advantages reported. In the case of upper limb exercise, Ries et 
al (2007) recommended unsupported endurance-type training. The two main types of 
training mentioned by Rochester (2003) were aerobic (endurance-type) training and 
strength training. Ortega et al (2002) determined the effect of different exercise training 
strategies in patients with COPD. They found that 6MWD test was improved most in the 
group undergoing strength training. However, the group undergoing endurance training and 
the group doing a combination of both types of training showed more improvement in 
submaximal exercise capacity. In the case of increase in strength, pertaining to muscle 
groups used in the exercises, the strength group showed similar levels of improvement to 
that seen in the combined group and this was more than that seen in the strength only 
group. All groups registered an improvement in dyspnoea ratings as measured by the CRQ.  
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Langer et al (2009) reported on the use of interval training and/or endurance training in 
patients with COPD and concluded that comparable results were obtained when the total 
amount of work performed was the same. Symptoms of dyspnoea were less during the 
achievement of high work rates when patients with COPD undertook interval training 
(Vogiatzis, Nanas and Roussos, 2002; Vogiatzis et al, 2005). Many interventions already 
described were for group therapy. Serres et al (1997) looked at individualized exercise 
training in patients with COPD and concluded that, when these patients exercised at the 
gas exchange threshold (GET) level, peripheral muscle performance was rapidly increased. 
 
Ries et al (2007), reporting on joint  ACCP/AACVPR guidelines, stated that PR 
programmes of a greater duration than 12 weeks showed better sustainable outcomes and 
the benefits achieved during 6-12 weeks of PR decreased gradually over 12-18 months. 
HRQoL remained above pre-intervention levels at 12-18 months. Liddell and Webber 
(2010) looked at a once/week supervised rehabilitation programme versus a twice/ week 
programme and noted similar improvements in exercise tolerance resulting from both. 
However, there was less improvement in HRQoL in the group that was supervised once a 
week.  
 
2.6.2 Inspiratory Muscle Training as a Component of Pulmonary Rehabilitation 
Garrod and Lasserson (2007) reported that the role of physiotherapists in the treatment of 
patients with chronic lung disease included the use of a variety of techniques to improve 
ventilation in order to achieve successful treatment outcomes. Hamilton et al (1995) stated 
that inspiratory muscle weakness in COPD was known to contribute to dyspnoea. The work 
done by Gosselink, Troosters and Decramer (1996) found that inspiratory muscle 
weakness was linked to exercise limitation. COPD was linked to a functional weakness in 
the inspiratory muscles caused by hyperinflation and the effects of exacerbations of the 
disease (Larson, Covey and Corbridge, 2002). They also found that the decrease in 
inspiratory muscle strength was associated with fatigue and dyspnoea. In a systematic 
review of 18 studies O‟Brien et al (2008) compared reported results in relation to inspiratory 
muscle training (IMT) versus exercise and combined IMT and exercise versus exercise 
alone. No significant difference in effect was noted in those cases where IMT was 
compared with exercise. However, the data suggested that a combination of IMT and other 
exercise interventions over a period of eight weeks at a rate of three times per week could 
be instrumental in increasing exercise tolerance and inspiratory muscle strength in patients 
with COPD. In a study, in which patients with COPD, underwent a 12 week general 
exercise reconditioning programme (GER) followed by a course of IMT or sham IMT with a 
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GER for six months Magadle et al (2007) found the GER and IMT programme beneficial to 
outcomes relating to 6MWD test, dyspnoea ratings and SGRQ score.  
 
Specific expiratory muscle training (EMT) was performed by patients with COPD daily, six 
times a week for 30 minutes per session and over a period of three months. An inspiratory 
muscle trainer was used with the patients breathing through the expiratory port  at a 
resistance equal to 15% of their maximum expiratory pressure (PEmax) for one week.The 
target of 60% of the baseline PE max  was achieved after one month by means of increments 
of five to ten percent per session. Each week after that further adjustment was made to the 
new PEmax achieved. This intervention resulted in a significant improvement in exercise 
performance (Weiner et al, 2003a). The same researchers (Weiner et al, 2003b) in a later 
study in the same year, looked at a comparison of EMT, IMT and a combination of the two 
treatment methodologies.They found that each individual muscular intervention resulted in 
an increase in strengthening and endurance in that particular muscle group. All 
interventions led to improvement in 6MWD test results but IMT and IMT combined with 
EMT showed greater improvement than EMT alone (Weiner et al, 2003b). Weiner and 
McConnell (2005) reviewed findings on IMT, EMT and a combination of these modalities in 
patients with COPD and concluded that strength and endurance can be improved when 
specific training is given to inspiratory or expiratory muscles; IMT results in an improvement 
in exercise tolerance, decreases dyspnoea and offers a better QoL; EMT leads to an 
increase in exercise performance; a combination of IMT and EMT probably results in no 
additional benefit. Beckerman et al (2005) found that a course of specific IMT over a year 
benefitted patients with COPD by decreasing dyspnoea ratings and improving QoL. It was 
also shown to be cost effective as it decreased the use of health services and 
hospitalization.  
 
2.6.3 Home-Based Versus Hospital-Based Rehabilitation 
No Cochrane review was sourced relating to home-based versus hospital based 
rehabilitation but there were a number of trials found and some will be reported. Larson et 
al (1999) reported that the effects of IMT and exercise training were previously only 
demonstrated in the inpatient and outpatient scenarios and so they examined the effects of 
cycle ergometer training (CET) and IMT in a home-based programme.Patients with COPD 
were randomised to one of four groups IMT, CET, IMT and CET or health education and 
were trained for a period of four months. A reduction in exercise related dyspnoea and leg 
fatigue was recorded with CET. However, this did not translate into a decrease in dyspnoea 
in ADL. Inspiratory muscle training increased inspiratory muscle strength and endurance. 
The combination of CET and IMT did not amplify any of the effects noted in the singlular 
interventions. In a clinical trial Battaglia et al (2006) examined the value of using a flow-
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volumeric inspiratory exerciser, named Respivol, in IMT undertaken by patients with COPD 
in the home environment. The patients used the inspiratory exerciser for a total period of 45 
minutes per day consisting of three 15 minute sessions and the trial lasted for a period of 
six months. Patients were assessed before the trial, at the three month stage and at the 
end of the six month period. The use of the exerciser seemed to have a beneficial effect on 
the 6 MWD test, dyspnoea and QoL ratings after six months of treatment. Ghanem et al 
(2010), in a randomised clinical trial, evaluated the use of a home-based PR programme 
undertaken over two months with outpatient supervision every two weeks. The programme 
consisted of respiratory muscle training (diaphragmatic breathing and pursed lip breathing), 
Endurance training (walking and cycling) and strength training and isolated muscle training. 
Significant improvement was seen in the 6MWD test, HRQoL, Arabic translated CRQ 
(CRQ-SAS) and the SF-36 scores. These authors recommended that questions that 
needed to be addressed, in relation to PR, were the long-term effects of early PR and the 
best location, format and length for a PRP. 
 
In summary, it has been shown that in the home –based setting patients with COPD benefit 
from CET, IMT or an intensive PR programme.  It appears that an effective home-based PR 
regimen can be implemented in order to address some of the problems experienced in the 
COPD population. However, there appears to be a need to relate such benefits to a better 
management of ADL in the lives of patients with COPD.  
 
2.7  HYDROTHERAPY 
2.7.1 Methods of Hydrotherapy Application 
Hydrotherapy is an umbrella term for different kinds of applications of therapy using water 
in its many forms. There are various methods of hydrotherapy application which include Ai 
Chi, Halliwick, Watsu and Bad Ragaz. In Ai Chi exercise is performed in 30oC to 35 ºC 
(thermoneutral) water up to shoulder level and utilises slow wide movements of the upper 
extremities, lower extremities and the torso in combination with deep breathing which is 
reported to benefit the internal organs particularly the heart, liver and lungs (Szirάki,1998; 
Kelsey, 2006). The Halliwick concept was first described by James McMillan in England in 
1949 and consists of a  ten-point motor learning programme which includes acclimatisation 
to water and rhythmic and rotational movements in water to improve balance. The final 
stage incorporates swimming with the type of stroke dictated by the patient‟s abilities and/or 
disabilities (Szirάki, 1998). Halliwick is usually performed as group therapy but each patient 
has an individual instructor who assesses and treats the patient accordingly. Breathing 
techniques are combined with the movements done in the water. The Watsu hydrotherapy 
method combines the stretches of Zen Shiatsu with the support of the water enabling the 
spine to move freely with no weight being placed on it and therefore facilitating spinal 
26 
 
 
 
muscle relaxation. This relaxation is reported to result in increased circulatory benefits with 
the removal of metabolites from the muscles resulting in a reduction of pain and fatigue 
(Kelsey, 2006). The Bad Ragaz ring method uses a combination of relaxation, stabilisation 
and progressive resistance exercises. The rings serve as flotation and stability aids. In the 
application the therapist serves as the fulcrum and is only immersed to the level of vertebra 
T9. The patient is supine and the treatment time is gradually progressed to a maximum of 
30 minutes. The exercise difficulty may be altered by the control of parameters such as the 
length of the lever arm, the range of movement, direction and size of the movement and the 
equipment used in the exercise session (Szirάki, 1998). 
 
2.7.2 Effect of Hydrostatic Pressure on the Cardiovascular and Respiratory Systems in 
Healthy Individuals 
 
Skinner and Thomson (1983) reported that, when a human body is immersed in a fluid, a 
resultant pressure is exerted on every part of the surface area of that body. This pressure, 
termed hydrostatic pressure, is exerted by the molecules in the fluid. Hydrostatic pressure 
is reported to affect pulmonary pressure balance (Hall, Bisson and O‟Hare, 1990; Anstey 
and Roskell, 2000). The hydrostatic pressure has both a direct and indirect effect on the 
respiratory system.  In a review Anstey and Roskell (2000) cited original work done by 
Agostoni et al (1966) where they reported that, during the process of chest expansion, the 
inspiratory muscles are required to work against this hydrostatic pressure as it causes a 
restriction in chest expansion. Anstey and Roskell (2000) also cited early work done by 
Jarrett (1965) who found that hydrostatic pressure alters the ratio between the intra-
pulmonary and extra-pulmonary pressure of the thorax in an immersed individual. For the 
chest to maintain a relaxed state and a normal resting volume these two pressures have to 
be equal. At normal resting volume, the intrapulmonary pressure in the relaxed, vertically 
immersed chest is equal to +19.0 cm H2O relative to the pressure at the sternal notch. 
Jarett (1965) also noted that the intrapulmonary pressure is 10.4 cm H2O, relative to the 
pressure at the sternum when the patient is immersed in the supine position; and that, in 
this same position in air the measurement is 3.4 cm H2O. Hall et al (1990) found that, 
during immersion to the supra-sternal notch in the seated position, the intrapulmonary 
pressure was +20.0cm H20 in relation to the hydrostatic pressure. Clinically this factor is 
taken into consideration by hydrotherapists when positioning subjects in the water. Different 
depths of immersion are used in order to minimise this imbalance. As these facts pertained 
to responses observed in healthy individuals, in the case of patients with lung pathology or 
rib deformity, treatment modifications were recommended by some authors (Anstey and 
Roskell, 2000). In this regard an increase in water temperature (up to 40oC) can lead to an 
increase in vital capacity (VC). This could possibly be linked to an increased synergy in 
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contraction of the respiratory muscles. A change in abdominal wall stiffness, due to the 
increased temperature of the water, could lead to an increased abdominal contribution to 
respiration (Choukroun, Kays and Varène, 1989). It seems feasible that if weak inspiratory 
muscles are unable to contract effectively to facilitate expansion of the chest wall against 
the hydrostatic pressure, selective lung volumes would decrease when the patient is 
immersed in water (Hall, Bisson and O‟Hare, 1990). These authors suggested that the 
pathology of a condition could affect the way the patient reacts to extra-pulmonary 
pressure. Greenleaf (1984), in a brief review, examined the effect of water immersion on 
patients subjected to prolonged bed rest in the horizontal position. He stated that 
compression of the abdomen by hydrostatic pressure could act indirectly upon the 
diaphragm forcing the diaphragm cephalad resulting in decreased space for thoracic 
structures. Agostoni et al (1966), using oesophageal balloons, concluded that there was a 
reduction in functional residual capacity (FRC) of 50% due to cephalad movement of the 
diaphragm. Agostoni did not take into account whether there were any pressures exerted 
from distended mediastinal structures in his calculations and the review by Anstey and 
Roskell (2000) reported that his findings remained unchallenged as more recent studies 
reviewed had not considered such pressure changes either. Sayliss (1995) and Anstey and 
Roskell (2000) suggested that water buoyancy acted like a support for the abdominal 
contents resulting in a decreased limitation of respiratory parameters during immersion.    
 
A marked increase in central venous pressure (CVP) was reportedly seen in healthy males 
during immersion in thermo-neutral water due to an increase in preload measure of stretch 
in the ventricular muscle just before it contracts (Christie et al, 1990; Gabrielsen, Johansen 
and Norsk, 1993; Park, Choi and Park, 1999).  During upright immersion in water to neck 
level it was shown that a movement of venous blood occurred from the periphery of the 
body towards the head causing an increase in central blood volume (CBV) (Park, Choi and 
Park, 1999). This vascular redistribution into the intra-thoracic vascular bed, of 
approximately 700 ml of blood, brought about an increase in pleural pressure in vulnerable 
areas and an increase in the weight of the lung. These factors contributed to a reduction in 
FRC (Lungren and Fahri, 1989). This increase in the thoracic vascular content also 
decreased the elastic recoil of the lungs at low lung volumes (Prefaut, Lupi–H and 
Anthonisen, 1976). The combination of the afore-mentioned changes favoured airways 
closure with a resultant increase in closing volume (CV) being reported (Bondi, Young et al, 
1976; Prefaut, Lupi-H and Anthonisen, 1976). The redistribution of blood volume centrally 
resulted in a lowering of HR, in healthy men, compared to that measured in air (Avellini, 
Shapiro and Pandolf, 1983; Christie et al, 1990; Lazar et al, 2008). Mano et al (1991) used 
head-out graded water immersion to simulate the neural and humoral controlling factors of 
cardiovascular functions in healthy subjects under conditions of weightlessness. They 
28 
 
 
 
found that cardiac output (CO) was increased with immersion even though the HR 
decreased. Similar results were reported previously by Hong et al (1969), Arborelius et al 
(1972) and Begin et al (1976) and Farhi and Linnarsson (1977). Further cardiopulmonary 
changes observed with head-out immersion were an increase in right atrial  pressure when 
the level of the water was raised from the diaphragm to the neck (Echt, Lange and Gauer, 
1974; Risch et al, 1978) accompanied by a resultant decrease in VC due to the increase in 
the pulmonary circulation (Risch et al, 1978). 
 
2.7.3 The Effect of Different Levels of Immersion on the Cardiovascular and Respiratory 
Systems in Healthy Individuals 
 
With immersion to the level of the xiphoid process VC, measured in litres, was found to 
decrease by 7.9% (Greene et al, 1974). This parameter reportedly decreases by 9.9% 
when immersion is to the level of the larynx (Bondi et al, 1976). During immersion to the 
neck it reportedly decreases by 8% (Farhi and Linnarsson, 1977; Risch et al, 1978) or by 
9% (Agostoni et al, 1966). Greene et al (1974) report that with immersion to the xiphoid 
process there is a decrease in FRC, measured in litres, of 10.4%. Farhi and Linnarsson 
(1977) detailed this decrease as being 400ml with immersion to the xiphoid level and a 
further 400 ml decrease with immersion to the neck. Central venous pressure increased as 
depth of water increased (Gabrielson, Johansen and Norsk, 1993). Risch et al (1978) 
recorded a 15% decrease in HR during immersion from xiphoid to neck. However, HR was 
found to decrease with increasing depth of immersion up to the xiphoid level but then it 
remained static up to neck level (Gabrielson, Johansen and Norsk, 1993). Central venous 
pressure increased with a rise in water level (Risch et al, 1978; Gabrielson, Johanssen and 
Norsk, 1993). The former researchers also found the greatest increase occurred when 
water level was raised from the xiphoid process level to C7. Pulmonary arterial pressure, 
CO and stroke volume (SV) all increased with increased depth of immersion (Lollgen et al, 
1981; Mano et al, 1991). The decrease by 9.4% in residual volume (RV) and by 41.3 % in 
CV shown by Bondi et al (1976) had an effect on the tidal volume (VT) in 90% of the 
individuals taking part in their study. 
 
2.7.4 The Effect of Different Water Temperatures on the Cardiovascular and Respiratory 
Systems in Healthy Individuals 
 
In the cold water study undertaken by Mekjavic and Bligh (1987) an immediate increase in 
ventilation was noted while sudden cold water stimulus to the skin was referred to as a 
“gasp” reflex by these authors. McArdle et al (1976) noted a higher VO2 level in subjects 
immersed in 18OC and 25oC water compared to results in air or thermoneutral water. SV 
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levels increased significantly in a similar manner to VO2 results in the cooler water 
temperatures. Šrάmek et al (2000) immersed subjects in water at 14oC, 20oC and 32o C in 
a random sequence with one week between each exposure. They reported that the 
intervention in 14oC water led to an increase in HR, SBP and DBP when compared to 
results obtained with a similar immersion in thermoneutral water. The tidal volume 
abdominal component (VT ABD) was decreased while the tidal volume ribcage component (VT 
RC) was increased during immersion at 25
oC (Choukroun, Kays and Varène, 1989). 
Choukroun, Kays and Varène (1989), after an intervention where subjects were immersed 
in thermoneutral water, confirmed the result previously reported by Craig and Ware (1967) 
where those authors found that VC was decreased significantly when subjects were 
immersed in water of either 27oC or 35.5oC. In their study where an intervention, in which 
water with a temperature of 40oC was used, Choukroun, Kays and Varène (1989) found a 
resultant increase in VC at this temperature. These researchers also show that inspiratory 
reserve volume (IRV) increases linearly with increments in water temperature while FRC is 
decreased in thermoneutral water. Increased water temperature has no effect on this 
parameter. Immersion at 39oC resulted in an increase in VO2 and CO (Boone, Westendorf 
and Ayres, 1999). These researchers noted an increase in HR but a decrease in SBP and 
DBP at this temperature after 15 minutes of immersion. 
 
Thermoneutral water was described as water with a temperature between 32OC and 35oC 
(Choukroun, Kays and Varène, 1989; Nakanishi, Kimura and Yokoo, 1999). However, in an 
early study Craig and Dvorak (1968) reported that, during dynamic exercise, the 
temperature of water required for thermoneutrality was lower than that used for static 
immersion experiments. Water temperatures between 29oC and 33oC were therefore 
recommended for aquatic exercise programmes (McArdle et al, 1976; Choukroun, Kays 
and Varène, 1989; Choukroun, Kays and Varène, 1990). However, on the basis of the 
results of their study Israel et al (1989) reported that, during exercise at approximately 60% 
of maximum oxygen consumption (VO2max), immersion in 25
o C and 21o C water prevented 
a rise in core temperature. However, the same exercise regimen in 29o C water led to an 
increase in core temperature. Hence these researchers concluded that, individuals of 
similar body composition and fitness level, performing cardiovascular exercise, in 21oC or 
25oC water temperatures would benefit from the cooling effects resulting from immersion at 
these temperatures. These researchers also reported that very low intensity hydrotherapy 
could be performed in 29oC water as they had found that static immersion at that 
temperature had resulted in a fall in core temperature in the subjects in their study. Israel et 
al (1989) concluded further that, the individuals in their study, had a perception of the 
temperature changes but not an accurate estimation of thermal balance  and they therefore 
recommended that it was important to monitor core temperature during aquatic exercise. 
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Variations in water temperature change the amount of thermal exchange through the skin 
(Choukroun, Kays and Varène, 1989). Wilmore and Costill (1994)  pointed out that the 
thermal conductivity of water was approximately 26 times that of air and rapid loss of body 
heat occurred by conduction and convection during immersion. The passage of water over 
the body during aquatic exercise further accelerates the heat loss (Datta and Tipton, 2006). 
Choukroun, Kays and Varène (1990) noted that the temperature of the water had no effect 
on diaphragmatic contraction but contraction of the more superficial rectus abdominis was 
subject to the effects of immersion at 25oC and 40oC. 
 
2.7.5 Submaximal and Maximal Workloads in Water for Healthy Individuals 
Barbosa, Garrido and Bragada (2007), in a study comparing physiological adaptations to 
aquatic exercise performed at different levels of immersion, found a higher RPE when the 
participants exercised with the water up to hip level as opposed to being immersed up to 
breast level. They concluded that RPE was higher in water up to hip level due to the drag 
forces associated with the lower limbs being greater than those associated with the trunk 
and upper limbs. It was reported by Barbosa, Garrido and Bragada (2007) and Barbosa et 
al (2009) that, with increasing body immersion, there was a decrease in VO2peak and energy 
expenditure. The reasoning behind these findings was that: increased depth resulted in an 
increase in hydrostatic pressure and reduction in cardiopulmonary workout; the action of 
anti-gravitational muscles in the lower limbs was negated by the buoyancy of the water; and 
dissipation of heat was greater when the subject was immersed in the deeper water 
(Barbosa, Garrido and Bragada, 2007; Barbosa et al, 2009). 
 
There are many different types of exercises described in the literature for head-out aerobic 
exercise programmes. Sanders (2000) categorised these as (a) running, (b) jumping, (c) 
rocking, (d) scissors (e) kicking and (f) walking. Barbosa et al (2009) stated that, because 
these basic exercise modalities could be adapted, combined or performed in isolation to 
many different degrees, it was hard to pin point the actual physiological  outcomes to be 
looked at the different outcomes arising out of a comparison of walking or running in water. 
In an early study Arborelius et al (1972) found that at rest in thermoneutral water or on land 
or performing moderate exercise in thermoneutral water or on land HR values were not 
significantly different. Whitley and Schoene (1987) conducted a trial which compared HR 
levels of healthy females performing water walking in waist- deep water and participating in 
land –based treadmill walking. They reported that water walking elicited significantly higher 
HR results than land-based treadmill walking. Hall et al (1998) reported that there was an 
increase in VO2 and HR, in healthy female subjects, with an increase in land-based treadmill 
or water-based treadmill speed. They also recorded that the HR readings were significantly 
higher when the participants exercised in 36oC water as opposed to 28oC water. Walking in 
31 
 
 
 
thermoneutral water while immersed to the level of the xiphoid process resulted in an 
increase in HR (Shono et al, 2000). Pohl and McNaughton (2003) noted that thigh-deep 
water walking raised the HR of their student participants significantly more than waist-deep 
water walking but that running at any depth elevated the HR of the participants the most. In 
regard to VO2 per stride it appeared that, due to the interaction between water resistance 
and buoyancy, no difference was seen in the energy expenditure demands for walking or 
running at any water depth. Oxygen consumption was raised in both walking and running 
scenarios, at both water levels, compared to land-based treadmill values. The respiratory 
exchange ratio (RER) was raised during running on land or in water. Pohl and McNaughton 
(2003) concluded, from the results obtained for HR, VO2 per stride VO2 and RER, that 
running in waist-deep and thigh-deep water seemed to induce a physiological response that 
could stimulate a training response with the added value of less impact forces being applied 
on the lower limbs during such training.   
 
Intense DWR was shown to be effective as an endurance training technique in competitive 
runners and, due to decreased impact forces, running in deeper water had better 
rehabilitation outcomes in the initial stages of rehabilitation (Ritchie and Hopkins, 1991). A 
progression to running in the shallower water to increase the intensity of the rehabilitation 
programme was recommended as VO2 levels were higher when trained runners ran in 
shallow water as opposed to running in deep water (Ritchie and Hopkins, 1991; Town and 
Bradley, 1991; Pohl and McNaughton, 2003). Nakanishi, Kimura and Yokoo (1999) 
reported that DWR resulted in a decrease in HR. In their review pertaining to physiological 
changes associated with DWR, Reilly, Dowzer and Cable (2003) reported that SV and CO 
increased during water immersion and suggested that this was due to the increased arterial 
blood volume activating the Bainbridge reflex. The resultant tachycardia effect counteracted 
the expected reflex bradycardia effect (Reilly, Dowzer and Cable, 2003). While DWR 
training had a sustained aerobic value in trained endurance athletes Reilly, Dowzer and 
Cable (2003) found that sedentary individuals benefitted more with regard to the 
improvement in VO2max.  
 
The HR of elderly participants during water walking was akin to that found when the 
subjects walked on land in contrast to the usual decrease in HR found with immersion of 
young, healthy individuals (Takeshima et al, 1997). These researchers validated the 
hypothesis that, when the elderly are immersed in water, the resultant vascular 
engorgement of the thoracic area leads to a different HR-VO2 relationship than that seen in 
younger subjects. The authors felt that this fact had to be taken into account when 
prescribing a water-based exercise regime for the elderly. Takeshima et al (2002) took 
healthy, elderly women and allocated 50% of the participants to a training group and 50% 
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to a control group. The water temperature was 30oC and the water level was approximately 
up to the xiphoid process. The training group underwent a 12 week water exercise 
programme. The well-rounded exercise programme resulted in a significant 12% increase 
in VO2peak and VO2 at a 20% lactate threshold (LT). This RCT would have a 1b rating on the 
hierarchy of evidence ranking system (Lloyd-Smith, 1997) (Table 4.2) and therefore the 
resultant 12% increase in VO2peak was a significant outcome. As there were no significant 
changes in the cardiovascular variables in the control group, the researchers concluded 
that such a water-based exercise programme was beneficial to the cardiovascular well-
being of elderly women. Broman et al (2006) looked at the cardiovascular effects resulting 
from a study on older women where they were required to do land-based treadmill running 
(TMR) and also DWR in 27oC water. The exercise protocol on the treadmill was paralleled 
by a programme of DWR where the participants increased the stride frequency to increase 
the work load in the water. The resultant HR, VO2 level and the ventilation rate was lower in 
the water at maximal work. However, at submaximal workload, the HR was higher in the 
aquatic environment. Nikolai et al (2009) investigated whether water aerobics, for a period 
of 50 minutes in chest-deep water, would give the 14 non-smoking male and female 
participants an alternative to a land-based exercise programme. The results led the 
researchers to confirm that the aquatic exercise was adequate to fulfil the required 
American college of sports medicine (ACSM) criteria for exercise in middle aged or older 
adults. 
 
2.7.6 The Role of Hydrotherapy in the Management of Chronic Diseases 
The use of water rehabilitation in musculoskeletal conditions was covered briefly earlier in 
this dissertation in relation to treatment outcomes for hip and knee replacements. In a pre-
operative population of hip or knee replacement patients Gill, McBurney and Shultz (2009) 
looked at pain and self-reported function as primary outcomes and timed walk and chair 
stand as secondary outcomes. The two groups, in the trial, performed a six week 
programme either land-based or water-based. The regimen included twice-weekly exercise 
classes. There were no differences reported between the two groups in relation to the 
primary and secondary outcomes during both interventions. However, immediately after a 
class there was a more marked decrease in pain associated with the aquatic therapy. 
Bartels et al (2007), in a Cochrane review, looked at studies that investigated the treatment 
of hip and knee osteoarthritis with aquatic therapy.No specific time frames were give for the 
duration of the interventions.The reviewers stated that exercises were undertaken for 
different lengths of time and for a differing number of sessions per week. They did report 
that the effects of the different interventions were mainly measured after three months. 
They concluded that, after an aquatic intervention, there was a small to moderate effect on 
QoL and function and pain was slightly reduced. They felt that this form of therapy would be 
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of particular value in the earlier part of an exercise programme for such patients. Elyan and 
Khan (2008) reported on a small study which demonstrated that hydrotherapy combined 
with home exercise as opposed to exercise alone had a significant short-term beneficial 
effect on pain, neck mobility and stiffness.in patients with ankylosing spondilitis. Waller, 
Lambeck and Daly (2009) in a review looked at whether there were beneficial outcomes 
from an aquatic therapy intervention in the management of patients with low back pain 
(LBP) or pregnancy- related back pain. They found that beneficial outcomes were reported 
in most studies and no study in their review reported negative effects of hydrotherapy on 
the condition of the patient. An aquatic intervention for patients with rheumatoid arthritis 
was undertaken by Bilberg, Ahlmen and Mannerkopi (2005). The primary outcome 
measured was aerobic capacity and this was found to be unchanged by the intervention. 
However, the secondary outcome measured was muscle endurance and hydrotherapy had 
a beneficial effect on this parameter. Evcik et al (2008) compared an aquatic therapy 
intervention to a home-based intervention in patients with fibromyalgia. The researchers 
looked at the effect of the intervention on functional capacity, depression, number of tender 
points and pain. Both interventions had beneficial outcomes for all four parameters but 
aquatic therapy resulted in pain relief over a time. 
 
Stroke had also been successfully treated with Bad Ragaz therapy which resulted in a 
reduction of muscular tone, increase of range of movement (ROM), relaxation, 
strengthening and muscle re-education (Sziraki,1998). Chu et al (2004) conducted a RCT 
to assess water-based exercise for cardiovascular fitness in people with chronic stroke 
using Ai Chi and Halliwick methods. The experimental group participated in chest deep 
water exercises over a period of an hour, three times a week. A resultant 22% 
cardiovascular improvement in the experimental group was reported (Chu et al, 2004). 
Another trial showed that postural balance and knee flexor strength were improved after 
such an intervention, over a period of eight weeks, in stroke survivors (Noh et al, 2008). 
 
Tanaka (2009) stated that there was evidence that swimming reduced the chances of 
regular swimmers developing some of the risk factors for cardiovascular disease. In a RCT 
of older patients with chronic heart failure the participants were randomised into either eight 
weeks of a hydrotherapy exercise programme or into a control group.The patients tolerated 
the intervention in the warm water well with no adverse effects being reported There was 
an improvement in maximal exercise capacity, muscle function in small muscle groups and 
in isometric endurance in knee extension over the results seen in the control group (Cider 
et al, 2003). Cardiac output was reportedly increased adequatelyduring water immersion, 
gymnastics and swimming in patients with heart failure. The symptom –limited exercise 
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stress test, carried out in thermoneutral water, was well tolerated by the patients (Schmid et 
al, 2007).   
 
2.7.7    The Pathophysiological Effect of Cold Water Therapy 
Goedsche et al (2007) addressed the pathophysiological effect of a cold water intervention. 
The study was not a dynamic exercise intervention and involved the application of cold 
water stimulations to the upper body. The researchers recorded increases in TNF-alpha, a 
factor associated with an increased inflammatory response in the body. In frail, elderly 
humans resistance exercise had decreased skeletal muscle TNF-alpha according to a 
study done by Griewe et al (2001). Goedsche et al (2007) cited work done by Rabinovich et 
al (2003) who had noted increased TNF-alpha plasma levels in COPD patients when they 
participated in moderate–intensity exercise. Evidence that chronic hypoxia in patients with 
COPD was related to the activation of the TNF-alpha system was offered by Takabatake et 
al (2000). These studies possibly highlight the fact that exercise intervention in patients with 
COPD was found to increase TNF-alpha levels. Elderly individuals who do not have COPD 
exhibit the opposite reaction as their TNF-alpha levels decrease with exercise (Griewe et al, 
2001). The fact that there was an increase in IFN-γ, a cytokine that is responsible for the 
effective defence against bacteria, and an increase in natural killer (NK)-cells was 
suggested to play a part against infection by Goedsche et al (2007). They suggested that 
their intervention was responsible for bringing about an immunological benefit to the 
patients in their study. Due to the fact that the patients experienced less infections during 
the follow-up phase and after the study period ended the argument that was put forward by 
Goedsche et al (2007) that the increased production of the NK-cells, thought to be 
responsible for this phenomenon, was a slow reactive process.  
 
In summary, no evidence was found in this literature review that a systematic review had 
been conducted on the topic of hydrotherapy in the management of patients with COPD. 
Available statistics point to an increase in the incidence of chronic disease (including 
COPD) worldwide. Aquatic exercise was shown to result in beneficial cardiopulmonary 
outcomes when used in healthy individuals and in the treatment of inflammatory conditions 
related to chronic musculoskeletal diseases. It is therefore relevant to investigate its role in 
the management of patients with COPD as reported by other authors. The next chapter of 
this dissertation will describe the methodology that was followed in order to conduct the 
systematic review. 
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CHAPTER 3  
 
3. METHODOLOGY 
The methodology discussed in this chapter is based on the findings of the literature review 
discussed in chapter 2. The study design, sample population, hypotheses tested, search 
strategy and data collation used are discussed in detail. 
 
3.1  STUDY DESIGN 
A qualitative systematic review was performed. 
 
3.2  RESEARCH HYPOTHESES 
 It is hypothesised that there is enough pertinent, up-to-date and clinically significant 
information available in the literature to produce a systematic review on the topic of 
hydrotherapy in the management of COPD. 
 It is hypothesised that the anti-inflammatory effects of exercise in land-based physical 
training apply to exercise in water. 
 It is hypothesised that hydrotherapy can be used with beneficial outcomes in the COPD 
population. 
 
3.3  SEARCH STRATEGY 
A search was made for relevant articles in the PUBMED, SCOPUS, MEDLINE, CINAHL 
and SPORTSDiscus databases and the Cochrane review database. Google scholar was 
perused in order to find any grey literature pertaining to the population under review.The 
review of the literature was from 1996 until 2009. This protracted period of 13 years was 
needed to ensure that all leading articles on the subject under review were included in the 
review. There were too few articles available from 2000 onwards to produce a valid review 
of the topic.The words and/or phrases used in the search were: hydrotherapy, Halliwick, Ai 
Chi, Watsu, Bad Ragaz, chronic obstructive pulmonary disease (COPD), pulmonary 
rehabilitation, emphysema, chronic bronchitis and the anti-inflammatory effects of exercise. 
After relevant studies were sourced through these databases the reference lists of these 
articles were perused to identify further references relating to the topic and these were then 
sourced through the relevant journal databases. This process was carried out until no 
further articles were identified for analysis. A hand search for any journal articles which 
could not be obtained electronically was conducted. An inter-library loan was requested 
when needed to obtain related articles.  
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3.4  INCLUSION CRITERIA 
Articles in the form of systematic reviews, randomised controlled trials, clinical trials and 
case studies pertaining to adult patients with non-acute, non-terminal COPD and the use of 
hydrotherapy were included in this review.  
 
3.5  EXCLUSION CRITERIA 
No articles based on animal studies were included. No articles on Kneipp therapy were 
included as hydrotherapy in this format does not include the immersion of the patient in 
water. 
 
3.6  DATA COLLATION 
Once the material was collected it was read and assessed for inclusion according to its type 
by two independent reviewers (DS and HvA). A hierarchy of quality of articles was 
established and the articles were evaluated using the LOW critical evaluation tool (Lewis, 
Williams and Olds, 2007). Although the LOW tool is mainly structured to evaluate RCTs it 
was chosen as it provided a comprehensive basis for the evaluation of the non-randomised 
trials in the studies under review and allowed for them to be accurately appraised and 
scored with a uniform methodology. The data were compared and similarities and/ or 
differences in results were noted. The results obtained were reported and the effectiveness 
of the treatment was assessed by looking at cardiopulmonary physiological outcomes as 
well as general outcomes. The review was a descriptive study but contains simple 
statistical data (in the form of tables) to record the quality of the material available for 
review and to afford correlation of the results and conclusions obtained from the information 
under review. 
 
3.7  DATA ANALYSIS 
An initial visual data analysis was undertaken to assess the availability, quality and 
relevance of data in the literature. As this was a qualitative analysis most reporting was of a 
descriptive nature. However, some results were tabulated to clarify the data. 
 
3.8  ETHICAL CONSIDERATIONS 
Ethical clearance for this study was obtained from the Human Research Ethics Committee 
of the University of the Witwatersrand, Johannesburg, South Africa (see Appendix B). 
Under no circumstances did this researcher copy or plagiarise another person‟s work. This 
researcher observed all copyright instructions. If there was a need to reproduce a table or 
figure from a study under review, the researcher undertook to contact the authors or 
publishers of that article and made a formal request, in writing, for permission to reproduce 
the item. The source was then cited in the text.  All articles, reports, books, any other form 
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of publication and web-sites used were cited within the text and within a comprehensive 
reference list at the end of the dissertation. Permission for the change of title of this 
dissertation was obtained from the appropriate authority (Appendix C).  
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CHAPTER 4 
4. RESULTS 
In order to assess the results in a logical, orderly and appropriate manner the guidelines put 
forward by Pai (2001), in the Cochrane Reviewer‟s Handbook 4.1.4 (October 2001) and the 
systematic review format used by Lewis, Williams and Olds (2007) were followed. 
 
4.1  IDENTIFICATION AND SELECTION OF STUDIES 
After a thorough search of the specified databases and the  perusal of reference lists on 
sourced articles, it was found  that there was a very limited number of studies, in the 
available literature, which investigated  outcomes related to an intervention using a 
population of patients with COPD and in which the intervention included an aquatic 
component.  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
Relevant articles were identified using different keywords or phrases within the same or 
different data bases.In some instances studies were duplicated, in different search engines, 
using the same input criteria (Table 4.1). No studies relating to any of the phrases or 
keywords were found in the Cochrane review data base or the CINAHL, MEDLINE or 
SPORTSDiscus databases. 
 
Thirty-seven studies were retrieved during the search. Nine studies met the inclusion 
criteria. All of these studies were published in full between 1996 and 2009. One of the 
included studies, translated from Portuguese, had an English abstract. The total number of 
patients involved in the included studies (n = 9) was 207 and the sample sizes in the 
individual studies varied between 10 and 43 participants. 
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Table 4.1: The Allocation of Studies According to Search Engines and Keywords or 
Phrases 
Keywords Search engine 
Number of 
studies retrieved 
Comment 
Hydrotherapy and 
chronic obstructive 
pulmonary disease 
Pubmed 
Scopus 
Google scholar 
5 
7 
1 
Four of these studies 
were  sourced through 
Pubmed 
Ai Chi and chronic 
obstructive 
pulmonary disease 
All search engines 0  
Halliwick and chronic 
obstructive 
pulmonary disease 
All search engines 0  
Watsu and chronic 
obstructive 
pulmonary disease 
All search engines 0  
Bad Ragaz and 
chronic obstructive 
pulmonary disease 
All search engines 0  
Pulmonary 
rehabilitation and 
hydrotherapy 
Pubmed 
Scopus 
Google scholar 
1 
1 
1 
These two studies were 
the same 
Chronic bronchitis 
and hydrotherapy 
 
Pubmed 
Scopus 
Google scholar 
2 
0 
1 
This study has already 
been sourced in Pubmed 
using the keywords 
hydrotherapy in chronic 
obstructive pulmonary 
disease. 
Emphysema and 
hydrotherapy 
Pubmed 
Scopus 
 
Google scholar 
3 
2 
 
3 
These two studies have 
been sourced through 
Pubmed 
Anti-inflammatory 
effects and 
hydrotherapy 
Pubmed 
Scopus  
Google scholar 
6 
16 
0 
 
 
 
Of the 37 studies sourced 28 did not meet the inclusion criteria for this review (Figure 4.1). 
Studies were excluded as follows: a) four of the studies fell outside the required 
chronological period of 1996 to 2009 [two studies on the topic of chronic bronchitis and 
hydrotherapy were dated 1973 and 1974 respectively, a study on emphysema and 
hydrotherapy was dated 1965 and was in German with no abstract available, a study on 
hydrotherapy and COPD was excluded as it was published in 1976]; b) a study on 
hydrotherapy and COPD did not meet the inclusion criteria as it had no abstract and was 
written in Japanese; c) although a total of 22 studies were sourced in relation to the anti-
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inflammatory effects of hydrotherapy none of the studies dealt with the treatment of COPD 
and were therefore excluded.  
 
 
 
 
Figure 4.1:  Study Selection Process 
 
 
4.2  DESCRIPTION OF THE STUDIES 
The focus and emphasis of this review is to assess the volume of evidence available and 
qualitatively review the literature on the role of hydrotherapy in the management of COPD. 
Using the inclusion and exclusion criteria, previously outlined, out of a total of 37 studies 
which were sourced, nine were considered to offer a resultant contribution to the topic unde 
review. Due to the limited number of studies on the subject the type of study for inclusion 
could not be limited to randomised controlled trials only.  
 
4.2.1  Volume of Evidence According to Lloyd-Smith (1997) Hierarchy 
The nine studies which were included in the systematic review were assessed using the 
Lloyd-Smith (1997) hierarchy of evidence in order to evaluate the type of study under 
examination. 
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Table 4.2:  Hierarchy of Evidence Ranking System (Lloyd- Smith, 1997) 
1a Meta analysis of randomised controlled trials 
1b One individual randomised controlled trial 
2a One well-designed, non-randomised controlled study 
2b Well-designed quasi-experimental study 
3 Non-experimental descriptive studies-comparitive/case studies 
4 Respectable opinion 
 
  
According to this methodology the studies fell into the following catagories: 
There were no studies which fell into the highest category of 1a.Two studies were allocated 
to the1b category (Wadell et al, 2004; Wadell et al, 2005). Two studies were classified as 
2a (Kurabayashi et al, 1998; Kurabayashi et al, 2000) and one study was classified as 2b 
(Severino, Morano and de Sousa Pinto, 2007). The remaining four studies fell into the level 
3 grouping (Perk, Perk and Bodén 1996: Kurabayashi et al, 1997; Kurabayashi, Machida 
and Kubota, 1998; Rae and White, 2009).    
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Figure 4.2: The LOW (Lewis, Olds and Williams) Critical Appraisal Tool   
Reproduced with the kind permission of L Lewis (Lewis, Williams and Olds, 
2007) 
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The LOW critical appraisal tool was used to evaluate the nine studies in this qualitative 
systematic review (Figure 4.2). All the included studies were similarly assessed and scored 
using the LOW format. On the advice of L. Lewis, of the LOW critical appraisal team, the 
critical appraisal scoring protocol applied was to answer the questions in each category and 
to apply a majority vote to the appraisal thereof. As is required in a valid systematic review 
two independent reviewers (DS and HvA) evaluated the available literature and discussion 
was held, where necessary, until consensus was reached regarding the quality of each 
study under review. 
 
Table 4.3:  Methodological Quality of the Included Studies (n = 9) Based on the 
LOW Critical Appraisal Tool 
Study 
LOW Critical Appraisal Rating 
1 2 3 4 5 6 7 8 9a 9b 
Total  
score 
Perk,Perk and Bodén, 1996 yes yes     yes  yes yes 5 
Kurabayashi et al, 1997 yes        yes  2 
Kurabayashi, Machida and 
Kubota,1998 
yes          1 
Kurabayashi et al, 1998 yes      yes    2 
Kurabayashi et al, 2000 yes yes    yes yes   yes 5 
Wadell et al, 2004 yes yes yes yes yes  yes  yes yes 8 
Wadell et al, 2005 yes yes yes yes yes  yes   yes 7 
Severino Morano and de 
Sousa Pinto, 2007 
yes     yes yes   yes 4 
Rae and White, 2009 yes yes    yes yes  yes yes 6 
 
As can be seen in table 4.3 the methological quality of the included studies ranged from 
one point (Kurabayashi, Machida and Kubota, 1998) to eight points (Wadell et al, 2004). 
However, it must be noted that only studies with a separate control group would be able to 
achieve a score of nine. Eligibility criteria, so that patient recruitment could be repeated, 
were not stated in five studies (Kurabayashi et al, 1997; Kurabayashi, Machida and Kubota, 
1998; Kurabayashi et al, 1998; Kurabayashi et al, 2000; Severino, Morano and de Sousa 
Pinto, 2007). Four studies had no exclusion criteria stipulated (Kurabayashi et al, 1997; 
Kurabayashi, Machida and Kubota, 1998; Kurabayashi et al, 1998; Kurabayashi et al, 2000) 
and one had no clearly defined inclusion criteria (Severino, Morano and de Sousa Pinto, 
2007). 
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The recruitment process was likely to produce bias in regard to the patients‟ positive or 
negative response to the intervention in five of the studies (Perk, Perk and Bodén; 
Kurabayashi et al, 1997; Kurabayashi, Machida and Kubota, 1998; Kurabayashi et al, 1998; 
Severino, Morano and de Sousa Pinto, 2007).  
 
A power calculation and justification for the sample size was given in only two of the 
included studies (Wadell et al, 2004; Wadell et al, 2005). These two studies also were the 
only studies to include a separate control group. 
 
The stability of baseline measurements and randomisation of interventions were not clearly 
stated in four studies (Perk, Perk and Bodén, 1997; Kurabayashi et al, 1997, Kurabayashi, 
Machida and Kubota, 1998; Kurabayashi et al, 1998). In the study by Kurabayashi et al 
(2000) the number of patients randomly assigned to each group and the order of 
interventions were not made clear. Whether the interventions were executed on the same 
day and the time of day they were done was also unclear. Outcome measurements were 
not measured accurately and therefore bias could not be minimised in two studies 
(Kurabayashi et al, 1997; Kurabayashi, Machida and Kubota, 1998). In the study by Perk, 
Perk and Bodén (1996) no clear indication was given by the authors as to the frequency of 
the intervention, the number of times the intervention occurred and the total duration of the 
intervention.  
 
No studies mentioned potential confounding factors or the possible impact of confounding 
factors on outcomes measured. However, two studies did mention that the sample size 
used was small (Wadell et al, 2005 and Severino, Morano and de Sousa Pinto, 2007).   
 
In the study by Wadell et al (2004) the researchers calculated the effect size (ES) for the 
ISWT, ESWT and SF-36. Otherwise no confidence interval data was given in any of the 
studies. Attrition/withdrawal data were not given in four studies (Kurabayashi, Machida and 
Kubota, 1998; Kurabayashi et al, 1998; Kurabayashi et al, 2000; Severino, Morano and de 
Sousa Pinto, 2007). 
 
The tools used for the calculation of QoL and ADL in two studies (Kurabayashi et al, 1997; 
Kurabayashi, Machida and Kubota, 1998) were possibly not appropriate for the 
measurements of these two parameters. In the study by Kurabayashi et al (1998) no 
analysis of data/variance (ANOVA) calculation was mentioned in the comparison of the two 
groups. 
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Overall there was a direct correlation between the LOW critical appraisal score rating and 
the methological quality of the studies. A small LOW score was a valuable indicator of the 
possible poor validity of the results and a high LOW score indicated a study with possible 
valid outcomes.         
 
The comparative analyses of each study by the two reviewers (DS and HvA), using the 
LOW critical appraisal tool, is shown in Appendix D. The two reviewers discussed points of 
difference in the scores and the final results of the LOW critical appraisal, of the included 
studies, is recorded in Table 4.3. 
 
4.2.2 Generalisability of Evidence 
All nine of the studies (100%) looked at the cardiorespiratory effects of hydrotherapy in the 
rehabilitative management of patients with stable COPD. As this was a review of 
hydrotherapy interventions the temperature of the water and the depth of immersion of the 
patients was an important consideration. Four studies (44%) used hot spring water at a 
temperature of 38oC; all other studies (56%) were done in thermoneutral water (29oC- 
34OC). All studies (100%) used the head-out methodology of immersion with the water level 
up to shoulder level. 
 
Therefore the generalisability of the evidence was classified as good as all researchers 
focussed on the rehabilitation of patients with COPD immersed to the same depth in water 
of a similar temperature. 
 
4.2.3  Participants 
The majority of the patients who participated in the studies were elderly and between 60 
and 80 years of age. However, in one study (11%) the age variable spanned 45 years (35-
80 years). 
 
Of the nine included studies (100%) which investigated the effects of a hydrotherapy 
intervention in the COPD population, two studies (22%) included both asthmatic patients 
and those with pulmonary emphysema categorising the patients as uniformly suffering from 
COPD. Two studies (22%) by Kurabayashi, Machida and Kubota (1998) and Kurabayashi 
et al (2000) stipulated that the patients with COPD were suffering from pulmonary 
emphysema and the other five studies (56%) did not categorise the patients into a COPD 
subgroup. All the patients in the included studies had stable COPD.  One study (11%) by 
Rae and White (2009) defined the patients‟ COPD level as mild or moderate. Four studies 
(44%) did not stipulate the patients‟ COPD level (Kurabayashi et al, 1997; Kurabayashi, 
Machida and Kubota, 1998; Kurabayashi et al, 1998; Kurabayashi et al, 2000). Calculation 
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of the COPD levels of the patients in the study by Perk, Perk and Bodén (11%) was 
possible from the FEV1 predicted levels given. The COPD level of the patients in this study 
was moderate to severe.Severino, Morano and de Sousa Pinto (2007), in their study (11%), 
stipulated that the patients had moderate to severe COPD. Only two studies (22%) (Wadell 
et al, 2004; Wadell et al, 2005) used the GOLD criteria, which stipulates 50%≤FEV1< 80% 
predicted for moderate COPD and 30%≤FEV1<50% predicted for severe COPD, as a 
definitive measure to report that the patients in their studies fell into the moderate to severe 
COPD category. These were the only studies (22%) that had a separate control group 
(Wadell et al, 2004; Wadell et al, 2005).   
 
An included study (Kurabayashi, Machida and Kubota ,1998), which measured the effect of 
hydrotherapy on EF, included four patients with  the New York Heart Association (NYHA) 
functional class I, six patients with NYHA functional class 2 and two patients with NYHA 
functional class 3 (Kurabayashi, Machida and Kubota, 1998). [NYHA functional class 1 is 
representative of mild heart failure with no limitation of physical activity; NYHA functional 
class 2 represents mild heart failure with slight limitation of physical activity and NYHA 
functional class 3 where there is moderate heart failure with marked limitation of physical 
activity].   
 
4.2.4 Intervention 
Four of the included studies (Kurabayashi et al, 1997; Kurabayashi, Machida and Kubota, 
1998; Kurabayashi, et al, 1998; Kurabayashi et al, 2000) looked at various applications of 
breathing exercises performed in a hot spring water pool. In two of the studies 
(Kurabayashi et al, 1997; Kurabayashi, Machida and Kubota, 1998) the breathing exercises 
were done with the patient breathing out into the water through the mouth while the nose 
was submerged 3-5 centimetres below the water surface.The duration of the session was 
30 minutes and the procedure was done six times a week for a period of two months. One 
of the other two studies (Kurabayashi et al, 1998), applying the same breathing regime, 
looked at three different breathing protocols (A,B and C) where the total exercise period per 
week in the first intervention (A) was 20 minutes per week (10min/day,2days/week); the 
second intervention (B) was 120 minutes per week (20minx2/day, at 10:00am and 3:00pm, 
3 days /week) and the third (C) was for 120 minutes per week (20min/day, 6days/week) 
(Kurabayashi et al, 1998). In the remaining study the breathing exercises were carried out 
in the water but one group breathed out into air while the other breathed out into the water 
(Kurabayashi et al, 2000).  
 
All the other included studies looked at varied PR programmes. Four of these studies 
looked at the same exercises being performed on land versus in water (Perk, Perk and 
47 
 
 
 
Bodén 1996; Wadell et al, 2004; Wadell et al, 2005; Severino, Morano and de Sousa Pinto, 
2007) and the fifth study was based entirely in a swimming pool (Rae and White, 2009). In 
the two studies by Wadell et al (2004) and Wadell et al (2005) there was a high intensity 
physical training programme incorporating 45 minute sessions three times a week for a 
total period of 12 weeks .The exercises in these studies had strength and endurance 
components and exercised the whole body (Wadell et al, 2004; Wadell et al, 2005). The 
study by Perk, Perk and Bodén (1996) involved three periods of submaximal dynamic arm 
and upper body exercise each lasting for three minutes followed by a two minute rest 
period for a total time of 15 minutes on land and 15 minutes in water. The land-based 15 
minute exercise session preceded the water-based session and there was a 10-15 minute 
rest period between the two sessions. It appears that this intervention was only performed 
once for a total duration of 30 minutes of exercise. Patients performed hydrotherapy once a 
week together with a land-based rehabilitation exercise programme twice per week in a 
study by Severino, Morano and de Sousa Pinto (2007). The exercises performed were from 
the Kabett diagonal weight and place system and the exercise programme lasted for three 
months. Rae and White (2009) assessed a hydrotherapy exercise programme incorporating 
12 sessions over a period of six weeks which consisted of upper and lower limb exercises. 
Education, by a multi-disciplinary team, about various matters relating to COPD, was 
included as part of the intervention by Severino, Morano and de Sousa Pinto (2007) and 
Rae and White (2009). 
 
4.2.5 Outcome Measures Assessed 
A total of 35 outcome measures were used in the nine included studies and were grouped 
into the following catagories: Cardiovascular; pulmonary; muscle strength/ weakness, 
endurance and power; QoL and ADL outcomes. 
 
The most commonly reported outcome was FEV1% (n = 6) with two of these measurements 
being calculated at baseline. (Forced vital capacity (FVC), PaCO2, PaO2 were used as 
outcome measures in four studies (n=4). Forced expiratory volume in one second, maximal 
expiratory flow at 25% (V25), PF, the Borg dyspnoea scale and ISWT were reported 
outcome measures in three studies (n = 3). 
 
4.2.5.1 The Cardiovascular Outcomes 
In a study, in which dynamic arm exercises were done on land for a 15 minute duration and 
after a 10-15 minute rest period were repeated in water for a period of 15 minutes, Perk, 
Perk and Bodén (1996) reported that the resting HR after training in water returned to 
pretraining levels more quickly than the resting HR after training on land. In an exercise 
programme using Kabett‟s diagonal weight and place exercises for the upper limb in which 
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Group 1 did hydrotherapy and a land-based PRP and Group 2 only did a land-based PRP 
programme, the researchers found that there was a significant decrease in HR in Group 1 
(p< 0.01) and Group 2 (p< 0.05). The decrease in HR was greater in Group 1. HR 
measurements were taken during the time that the weights were being changed 
(increased).The programme ran for a period of three months with the patients exercising 
three times a week. Group 1 exercised once a week in water and twice a week on land 
(Severino, Morano and de Sousa Pinto, 2007). The mean HR, during training sessions, was 
shown by Wadell et al (2004) as a percentage of peak heart rate and overall was found to 
be lower in patients exercising in water for 12 weeks. However, during the cycle ergometer 
training in the water, a small but significant increase in peak heat rate (HRpeak) was 
recorded (Wadell et al, 2004).  
 
Perk, Perk and Bodén (1996) reported a decrease in SBP of 14mmHg and a decrease in 
DBP of 6mmHg when the patients with COPD were immersed in water compared to the 
resting values on land. The researchers pointed out that, because the land-based exercise 
programme and the subsequent 10-15 minute rest period preceded the water–based blood 
pressure readings, the method employed might have some impact on recorded blood 
pressure readings. The blood pressure values were given as mean plus standard deviation 
(+SD) but it was not clear in this study as to whether it was a singular intervention or 
whether the intervention took place over a number of times. No information regarding the 
number of times the measurements were taken or intervals between measurements or total 
duration of the intervention were stipulated by the researchers.  
 
Ejection fraction was the primary outcome measured in a study by Kurabayashi, Machida 
and Kubota (1998) in which the intervention involved a programme of breathing exercises 
in water for 30 minutes per day, six days a week over a period of two months.the 
researchers reported that the EF was significantly increased after each 30 minute exercise 
session (p<0.01) and was also significantly increased at the end of the two month 
programme (p<0.05). In a comparison of three breathing exercise protocols, undertaken in 
water, by Kurabayashi et al (1998). EF was increased significantly in all three groups 10 
minutes after exercise on the first day (p< 0.01) but there was no increase reported after 24 
hours after the exercise session on the first day. The longer intervention periods of 120 
minutes per week in protocols B and C proved to result in a significant improvement in EF 
at the end of the study period (after two months). 
 
Kurabayashi, Machida and Kubota (1998) measured  LVd and LVs dimensions and found 
that the LVdand LVs dimensions, at rest, decreased significantly after the two month 
exercise programme of breathing exercises in water (p< 0.01). 
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4.2.5.2 The Pulmonary Outcomes 
Many pulmonary outcomes were measured across the nine included studies. Six studies 
(n=6) reported on t he predicted FEV1% but in two studies these measurements were 
recorded in baseline data only, Four of the included studies (n=4) listed outcome data for 
predicted FVC, Pa CO2 and PaO2. Three studies (n=3) reported results for V25, FEV1, PF 
and Borg ratings for dyspnoea (one only measured this outcome at baseline). The ratio of 
FEV1/FVC, SaO2, VO2peak and RR were reported in two of the included studies (n=2). Rate 
pressure product (RPP), peak expiratory flow (PEF), maximum expiratory flow at 50 % 
(V50), VC, CRQ-SR rating for dyspnoea, base excess (BE) and the acid/alkaline level (pH) 
of arterial blood were each only recorded once (n=1) within two studies. 
 
The two included studies which looked at breathing exercises in water where the patients 
exhaled into the water for an exercise period of 30 minutes a day /six days a week for two 
months both reported a significant increase in FEV1% (p<0.37 and p< 0.05 respectively) 
(Kurabayashi et al, 1997; Kurabayashi, Machida and Kubota, 1998). These two studies 
reported no significant outcomes relating to FVC% but both recorded a significant decrease 
in PaCO2 levels with no change in PaO2 levels after two months of hydrotherapy. 
 
In the study by Kurabayashi et al (1998), where three hydrotherapy breathing protocols 
were tested, a significant increase in FEV1% (p< 0.01) was recorded in protocols B and C. 
No significant change was noted in FVC% in any of the three protocols. The PaCO2 levels 
were significantly decreased with protocol B (p< 0.05) and protocol C (p<0.05). However, 
the PaO2 levels were increased with protocol B only (Kurabayashi et al, 1998). 
 
Kurabayashi et al (2000) reported on a study where patients participated in a breathing 
exercise programme in water. Group A exhaled into the water while Group B, similarly 
immersed in the water, exhaled into air. FEV1% was significantly increased in the patients 
in Group A (p< 0.018). There was also an inclination towards an increase in FVC% in 
patients in Group A (p< 0.058) and significant increase in PaO2 levels (p< 0.010) and a 
decrease in PaCO2 (p<0.040) in this group. Group B showed no change in PaCO2 or PaO2 
levels (Kurabayashi et al, 2000).   
 
Peak flow reportedly showed a tendency to increase in a study of breathing exercises in 
water where the patients with COPD exhaled into the water (Kurabayashi et al 1997). It was 
found to increase in patients with COPD in Group A, who exhaled into water as opposed to 
Group B who exhaled into air in a study by Kurabayashi et al (2000) and was increased 
significantly in protocols B and C (p< 0.05) in a study by Kurabayashi et al (1998). 
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Maximum expiratory flow at 25% was not found to change in three of the included studies 
(Kurabayashi et al, 1997; Kurabayashi et al, 1998; Kurabayashi et al, 2000). In one of the 
included studies maximum expiratory flow at 50% (V50) and the ratio of V50/V25 also 
remained unchanged (Kurabayashi et al, 1997). 
 
Dyspnoea ratings, according to the Borg scale, were found to be higher both in the 
horizontal and the vertical pulling exercises in water (p<0.01) and this was more marked in 
the patients who had a poorer lung function (Perk, Perk and Bodén, 1996). Ratings for 
dyspnoea averaged a score of four on the 0-10 Borg scale in both training groups (on land 
or in water) during the physical group training sessions performed in a study by Wadell et al 
(2004). The ratings for perceived exertion (6-20 Borg scale) averaged 14 (Wadell et al, 
2004). In the study by Severino, Morano and de Sousa Pinto (2007) the patients in the 
water group seemed to be able to have a greater tolerance to the loads imposed on them 
before complaining of dyspnoea and they also rated the degree of their dyspnoea lower 
than those in the land-based group. After a swimming pool-based  PRP of 12 exercise 
sessions over a period of six weeks significant improvements in the dyspnoea scores, 
according to the CRQ-SR, were seen in the participants (Rae and White, 2009).(No SD 
statistical data were reported). 
 
Only one of the included studies looked at BE and the pH of arterial blood. The researchers 
found no change to these outcomes compared to baseline after the programme of 
breathing exercises conducted in water over a period of two months (Kurabayashi et al, 
1997). Although,during a cycle ergometry test, the VO2peak was increased in all three groups 
in a study looking at group physical training in water and on land (including a control group 
with no intervention) a significant increase was seen in the control group (p<0.018) and in 
the water group (p< 0.008). However, the researchers state that it is questionable whether 
the improvement in the control group is clinically relevant (Wadell et al, 2004). 
 
There was a significant improvement in SaO2 levels (p< 0.008) in the group that underwent 
training once a week in a pool together with two land-based exercise sessions compared to 
the group which only underwent land –based exercise three times/ week (Severino, Morano 
and de Sousa Pinto, 2007). SaO2 levels exhibited by the water group showed a 33.3% 
improvement over those recorded for the land based PRP group, after the 12 week 
programme .The oxygen saturation showed a significant 2% (p< 0.05) fall during the 
vertical pulling arm exercises conducted in water in the study by Perk, Perk and Bodén 
(1996).The other dynamic arm exercises had no effect on the SaO2 levels in the outcomes 
of this particular study. In the same study it was reported that, with immersion in the water, 
VC was significantly decreased by 12% (p< 0.001), FEV1 significantly decreased by 14% 
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(p<0.001), PEF significantly decreased by 18% (p< 0.001) but the ratio FEV1/VC remained 
the same. Very little difference, compared to baseline measurements, was seen in FEV1 
and FEV1/ FVC in the swimming pool-based study by Rae and White (2009) (No SD data 
were given for these parameters). 
The RR decreased significantly (p< 0.046) after a three month aquatic exercise intervention 
in the study by Severino, Morano and de Sousa Pinto (2007). However, Perk, Perk and 
Bodén (1996) contrarily noted that, during some of the exercises performed in water in their 
study, breathing required more effort. Both of these studies looked at exercises performed 
with the upper limbs in an aquatic environment. Perk, Perk and Bodén (1996) used a 15 
minute regimen of submaximal dynamic arm and upper body exercises (three exercises 
performed for three minutes each with a two minute rest period between each exercise), 
firstly performed on land and then in water for a total exercise time of 30 minutes per 
session. The exercise regimen included horizontal (rowing action and curtain closing 
action) and vertical (bucket lifting action) weight pulling exercises. Severino, Morano and de 
Sousa Pinto‟s (2007) study used Kabett‟s diagonal weight and place system and was 
carried out once a week in the water and once a week on land in the water group and twice 
a week on land in the land group. The programme was continued for 12 weeks. Perhaps 
the improved physical conditioning and fitness of the patients due to the length of the 
intervention in the study by Severino, Morano and de Sousa Pinto (2007), accounted for the 
reported beneficial outcomes. The total duration of the intervention by Perk, Perk and 
Bodén (1996) was not clearly stated and so it is difficult to assess whether it was of shorter 
duration than that of Severino, Morano and de Sousa Pinto (2007) and whether physical 
conditioning or lack therof was reflected in the response seen in the patients with COPD in 
the study by Perk, Perk and Bodén.  
 
4.2.5.3 Muscle Strength/Weakness, Endurance and Power 
Wadell et al (2004) conducted a trial in which patients with COPD performed high intensity 
physical training in water or on land for 45 minutes per session, three times a week for a 
period of 12 weeks. These researchers reported an increase in walking distance for both 
groups. In the ISWT (the result was significant in the land group) and in the ESWT (the 
result was significant in the water group).The mean effect size (ES) values with 95% 
confidence intervals were given for these results. During the cycle ergometer tests in the 
same study both the water group and the land group increased the time cycled. Mean 
workload was also increased significantly across all three groups with an increment of 6.7, 
9.3 and 10.0 W for control, water and land groups respectively. Only baseline data relating 
to between-group comparisons for ISWT and ESWT in the land group, water group and 
control group were reported by Wadell et al (2005) and these data were not significant. 
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After an aquatic intervention of 12 sessions of exercise over six weeks in a swimming pool 
Rae and White (2009) reported that ISWT scores improved significantly.     
In a study by Wadell et al (2005) the focus of the research was on the effects of a three 
month physical training programme on muscle performance in patients with COPD. 
Maximal dynamic strength and endurance of the thigh muscle was measured pre and post 
training.  The patients that were randomised to the land-based intervention group improved 
in both maximal dynamic extension by16% (p< 0.009) and in maximal dynamic flexion by 
27% (p< 0.006). Improvements in maximal dynamic flexion of 40% (p< 0.001) and 7% (p< 
0.016) were noted in the water-based intervention group and the control group respectively. 
In the water-based intervention group there was an improvement of 8% in maximal dynamic 
extension (p<0.023). The endurance test resulted in no significant change observed in any 
of the groups. The researchers also noted a high non-responder grouping with regard to the 
ability to perform 100 knee extensions at baseline. They noted some degree of correlation 
between lower body mass index (BMI) and better strength in knee extension (Wadell et al, 
2005).They concluded that physical training on land or in water has beneficial outcomes 
regarding maximal thigh muscle strength in patients with COPD. 
 
Severino, Morano and de Sousa Pinto (2007), using the Borg tool, found that upper limb 
fatigue  changed little between the group that  performed the exercise in water as well as a 
land-based PRP compared to the group who only performed  the land-based PRP. The 
study by Perk, Perk and Bodén (1996) was the only one to record a rating of effort using 
the Borg scale for this parameter. These researchers found that during exercise 1, 
horizontal weight pulling as in a rowing motion, a resultant significant increase in this rating 
from 12-14 (p<0.01) was recorded. Wadell et al (2004) reported that the physical 
component score (PCS) of the SF-36 showed that the water intervention produced a 
significant improvement (p=0.015) in physical health. This study demonstrated that the 
mean workload was improved in the water group compared to that in the control group.  
 
With regard to maximal load Severino, Morano and de Sousa Pinto (2007) reported that the 
patients in the group which had the hydrotherapy component in their regimen performed 
better than those in the land-based group. They qualified this observation by saying that 
those patients were able to withstand higher loads during the intervention, showing a 
greater physical fitness. 
 
4.2.5.4 Quality of Life (QoL) and Activities of Daily Living (ADL) Outcomes 
Wadell et al ((2004), using the SGRQ, found that the patients in the water group showed a 
small significant improvement in total score but also showed a significant decrease in 
activity score where the decrease was by 5.1 points and four units was regarded as the 
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threshold for clinically significant change. This was regarded as significantly improved 
compared to the other two groups (p=0.009). The control group showed deterioration 
according to the SGRQ rating system which was reported to be significant (p=0.034). 
According to the generic SF-36 questionnaire, Wadell et al (2004) found that the PCS for 
their patients were lower than those recorded for the general Swedish population over 65 
years of age. The mental component scores (MCS) were compatible. However, an increase 
of six points in the PCS for the water group post intervention was considered to be a 
clinically important difference and this change was significant compared to the other two 
groups. The ES achieved in their study for exercise capacity and HRQoL were between 0 
and 0.7 in the water group, between 0 and 0.3 in the land group and between 0 and -0.4 in 
the control group. In the study by Kurabayashi et al (1997) the modified version of the 
Flanagan (Flanagan, 1982) classification was used to assess changes experienced by 
patients with regard to QoL. Of the 22 patients in the study five showed objective signs of 
improvement in their QoL. Kurabayashi et al (1997) used the Hugh-Jones (Hugh-Jones, 
1952) classification to assess functional performance .The authors recorded that five of the 
patients demonstrated objective improvement on this scale. Kurabayashi, Machida and 
Kubota (1998), using the same classification tool, found that after discharge five patients 
showed an improved QoL. Rae and White (2009) used a subjective evaluation of the 
treatment by the patients with COPD. Qualitative interviews, conducted after the 
intervention, were audio-taped, transcribed and analysed. Patients evaluated the 
programme as good or very good. According to the emotional scores and mastery scores 
before and after the intervention as measured by the CRQ-SR tool there was an 
improvement in both these parameters. However, the researchers did not give SD 
information for these data. 
 
The calculation of ES is a reliable method to assess the degree to which a specific 
intervention influenced the outcomes measured. The LOW critical appraisal tool (Question 
9a) was used to determine whether the ES was presented or could be calculated from the 
data presented in the included studies. Although five of the included studies reported on 
mean and SD data for outcomes assessed as well as the size of the p value (Perk, Perk 
and Bodén, 1996; Kurabayashi et al, 1997; Kurabayashi et al, 1998; Wadell et al, 2004; 
Severinol, Morano and de Sousa Pinto 2007) it was not possible to assess ES as these 
authors did not assess similar outcome measures and there were no control groups in their 
study designs except for Wadell et al (2004). Wadell et al (2004) had reported on ES for the 
ISWT, ESWT, MCS and PCS. It was also not possible to assess ES for the semi-
randomised RCT conducted by Wadell et al (2005) as the authors presented their data in 
the form of medians and interquartile ranges and not means and SD. 
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CHAPTER 5 
5. DISCUSSION 
This qualitative systematic review looked at the specific population of patients with COPD 
and the effect of hydrotherapy management of their disease. It examined how hydrotherapy 
influenced cardiopulmonary outcomes, endurance, the patient‟s ability to perform ADL and 
the HRQoL in patients with COPD. It also tried to establish whether there was any evidence 
connecting exercise in water to an anti-inflammatory effect similar to that seen in land-
based exercise. 
 
The fact that only nine studies met the inclusion criteria for this qualitative systematic 
review attested to the fact that there were very few studies which assessed the role of 
hydrotherapy in the management of COPD. The range of scores that the studies obtained 
on the “LOW” critical appraisal rating tool showed that the included studies were of varied 
quality. Therefore, in the interpretation of the results and conclusions drawn from these 
studies, the LOW critical appraisal scores were taken into account when considering the 
possible validity of the researcher‟s findings.The limited information on the topic, the 
diversity of the interventions and very few related measured outcomes also made accurate 
assessment of the validity of the results difficult.  
 
The cardiopulmonary outcomes were examined in relation to a number of interventions. 
The included studies (n=4), which examined the role of breathing exercises being 
undertaken in hot spring water (38oC), produced some interesting results. It was noted that 
the cardiovascular parameters showed positive increases when these were examined in 
the three studies involving immersion with inhalation in air followed by exhalation into water. 
In relation to the pulmonary parameters the pulmonary measurements showed positive and 
beneficial outcomes for the patients with COPD when immersion was linked to the act of 
exhaling into the hot spring water. In particular, an improvement in the blood gas results 
(PaCO2 decreased and PaO2 increased) was noted when the patients breathed out into the 
water. When the patients were instructed to breathe out into air, while immersed in the 
water, no improvement in these parameters was noted and this appears to indicate that the 
exercise of exhaling into the water had the beneficial effects seen in the results obtained. A 
possible explanation for this finding is that exhalation against the pressure of the water 
would create a positive expiratory pressure in the airways. This positive expiratory pressure 
would open partially collapsed airways as it assists with secretion clearance through 
collateral ventilation pathways between the alveoli and bronchioles. This would create a 
greater surface area for gas exchange, hence the improvement in ventilation observed 
(Pryor and Prasad 2008, 151). Expiration against resistance enforces more work on the 
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inspiratory muscles to overcome this resistance and therefore increases lung volumes 
which would lead to improved ventilation (Fagevik-Olsen, Lonroth and Bake 1999; Lumb 
2005, 49-50). 
 
It was demonstrated that, when such a breathing exercise regime, in water, had a duration 
of 120 minutes/week (Kurabayashi et al, 1998) or 150 minutes /week (Kurabayashi, 
Machida and Kubota, 1998), a significant improvement was achieved in cardiopulmonary 
outcomes when compared to those achieved in an intervention of only 20 minutes/week 
(Kurabayashi et al, 1998). However, it was also demonstrated that PaCO2 decreased most 
when the exercise programme was performed once a day for six days a week as opposed 
to twice a day for three days per week. Sessions were of 20 minutes duration in both 
scenarios (Kurabayashi et al, 1998). Partial pressure of oxygen in arterial blood was only 
seen to increase significantly (p< 0.01) in protocol B of the study, which consisted of 
breathing out into water for 20 minutes, twice a day (once in the morning and once in the 
afternoon), for three sessions a week over a period of two months (Kurabayashi, Machida 
and Kubota,1998). 
 
Hence, it appears that physiotherapy for COPD, in the form of a hydrotherapy breathing 
regime, may require an intervention of a particular duration and frequency to improve 
clinical parameters.However, the validity of these findings was questioned by this 
researcher as the three studies from which this assumption has been made had a poor 
rating on the LOW critical appraisal scale.  
 
As previously reported in 2.6.1 of this review, Weiner et al (2003a) concluded that when 
land-based EMT was performed by patients with COPD over a period of three months a 
significant improvement in exercise performance was noted. Weiner and McConnell (2005) 
concluded that strength and endurance can be improved when specific training is given to 
expiratory muscle groups. They also concluded that EMT leads to an increase in exercise 
performance. The findings in the aquatic breathing exercise regimens reported by 
Kurabayashi et al (1997); Kurabayashi, Machida and Kubota (1998); Kurabayashi et al 
(1998) and Kurabayashi et al (2000) have suggested beneficial cardiopulmonary outcomes 
when patients with COPD make an expiratory muscle effort in order to exhale into water. 
Therefore, this type of breathing exercise should perhaps be considered as an alternative 
form of EMT in patients with COPD.   
 
In the cases where the intervention for the patients with COPD was an aquatic physical 
training programme, either alone or in comparison to a land-based intervention (n=4), a 
shorter aquatic exercise programme of 15 minutes was not seen to be instrumental in 
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changing the HR parameter which was measured during the exercise session and also 
during the 10-15 minute rest period after the exercise session had been completed. 
However, it was noted by the researchers that post training resting HR levels on land did 
not return to resting pretraining levels to the same extent as post training resting HR levels 
in water.Systolic blood pressure and DBP, when measured at rest in water, showed 
beneficial decreases. The study by Perk, Perk and Bodén (1996) from which these data 
were taken did not stipulate a total length of time for the duration of the intervention and it 
seems possible that it was a once-off intervention. In 12 week hydrotherapy interventions 
the HR was shown to decrease during the training period. It has been documented that 
immersion up to the xiphoid level (shoulder level) results in a decrease in HR, even without 
physical activity (Lollgen et al, 1981; Gabrielson, Johansen and Norsk, 1993). A decrease 
in HR due to immersion alone, which should have been seen in the shorter exercise 
intervention, was possibly counteracted by an increase in HR brought about by the short, 
intense exercise intervention thus resulting in an overall stabilisation of the HR.    
 
In general, dyspnoea ratings for the physical training interventions in four of the included 
studies with both land–based and water-based interventions and one with only an aquatic 
component (n=5), were low especially in relation to the longer duration interventions. When 
dynamic upper limb and trunk exercises were done in water for a period of 15 minutes the 
Borg ratings for dyspnoea were raised and were especially increased in the patients who 
had poorer lung function. In the 12 week hydrotherapy and PR intervention, where the 
patients with COPD performed Kabett‟s diagonal weight and place exercises with the upper 
limbs, the perception of dyspnoea was seen to be delayed during the exercise programme 
in the water and was of a lower rating when assessed. This type of effect was also shown 
when patients with COPD took part in a swimming pool- based physical training programme 
for a period of 12 weeks and an average Borg scale rating of four was seen in another 
physical training intervention over a period of 12 weeks. All three of these advantageous 
results for the reduction of dyspnoea were seen to be associated with an aquatic 
intervention once, twice or three times per week over a period of 12 weeks. The frequency 
of application of the intervention varied; the interventions, although of a physical nature also 
varied and the only common denominator to all three studies seemed to be the total 
duration of the intervention period (12 weeks). As the scores for dyspnoea for the 15 minute 
intervention were raised but for the longer interventions were decreased there may be a 
case to suggest that hydrotherapy interventions involving physical exercise programmes in 
patients with COPD could have favourable outcomes in relation to the reduction of 
dyspnoea if the intervention lasted for at least 12 weeks. In general no detrimental effects 
of hydrotherapy on cardiopulmonary outcomes were reported.  
57 
 
 
 
Dysfunction of the skeletal muscles has been recognised as part of the COPD profile 
(Casaburi, 2001).The hydrotherapy physical training interventions for patients with COPD 
included in this review looked to address the weakness of the skeletal musculature. Wadell 
et al (2005) conducted a three month trial to assess the performance of thigh muscle in 
patients with COPD undergoing a specific physical exercise programme. They conducted 
the test on land and in water and found that training in either environment resulted in an 
improvement in thigh muscle strength but muscle endurance remained at pre-training 
levels. Increases in work load achieved through cycle ergometry (Wadell et al, 2004), 
distance walked and endurance on the ISWT (Wadell et al, 2004; Rae and White, 2009) 
and ESWT (Wadell et al, 2004)), duration of time spent on the cycle ergometer (Wadell et 
al, 2004), maximal dynamic knee flexion and to a lesser extent dynamic knee extension 
(Wadell, 2005) were reported in relation to hydrotherapy intervention. It may be concluded 
from these results, although few in number, that aquatic physical exercise training 
programmes might have some value in raising the functionality and strength of the skeletal 
muscles in patients with COPD and have an effect on endurance related functions such as 
walking. Man et al (2009), in a review on exercise and muscle dysfunction in COPD, 
concluded that an increase in quadriceps muscle strength combined with an increase in 
endurance was reported by some researchers after a land-based PRP. These authors also 
reported that a decrease in fatigability of the muscle, a small increase of the fat-free muscle 
mass and CSA was also found in the studies included in their review. These findings 
substantiate the reported improvement in quadriceps muscle strength observed by Wadell 
et al (2005) in relation to the land-based portion of their intervention and may lead to the 
conclusion that the water-based result may also be feasible. The studies (n=3) which 
reported these findings were above average according to the LOW critical appraisal rating 
tool and therefore their findings may be more objectively valid. Therefore, hydrotherapy 
may be a good alternative form of exercise intervention.    
 
The St George‟s respiratory questionnaire results and PCS results (obtained from the SF-
36 questionnaire) demonstrated that a hydrotherapy intervention of physical training led to 
significant improvement in the areas relating to QoL (Wadell et al, 2004). Positive results 
were demonstrated on the CRQ-SR in the study by Rae and White (2009) where patients 
with COPD took part in a swimming pool based PR programme of 12 sessions of exercise 
over six weeks. Although a modified version of the Flanagan classification (Flanagan, 1982) 
was used to assess QoL in two studies the format for the application of the tool was not 
clear. The two studies using this tool reported that QoL was improved with the hydrotherapy 
intervention. However, the studies were of a poor quality as shown by the LOW critical 
appraisal rating tool. With regard to ADL the studies by Kurabayashi et al (1997) and 
Kurabayashi, Machida and Kubota (1998) used the Hugh-Jones classification tool (Hugh-
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Jones, 1952) where this tool is used to relate the ventilation cost of the performance of a 
step test to the degree of breathlessness in the patients. It is not related to any specific ADL 
and therefore the choice of its use in order to assess ADL outcomes is questionable. This 
classification tool is also of a vintage nature and the Borg classification for dyspnoea is 
widely used and accepted today. The subjective evaluation of participants‟ experience of 
aquatic therapy was also offered as proof that group hydrotherapy improves QoL and the 
performance of ADL in patients with COPD (Rae and White, 2009).  
 
The small sample size, the issue of COPD exacerbations and patients‟ difficulty with the 
commute to the swimming pool were raised as factors which influenced the number of  
patient participating ,at any given time, during the combination aquatic and land-based 
intervention in the study by Severino, Morano and de Sousa Pinto (2007). Gender related 
differences in regard to certain outcome measurements were reported by Wadell et al 
(2005) and Severino, Morano and de Sousa Pinto (2007) but both sets of researchers did 
not feel that the data were tainted by this fact. 
 
Various authors,[Craig and Dvorak (1968); McArdle et al (1976); Choukroun and Varène 
(1989) and Choukroun, Kays and Varène (1990)], while conducting trials with healthy 
individuals, recommended that a water temperature between 29oC and 33oC should be 
regarded as thermoneutral for the purpose of physical exercise programmes in water. As 
previously mentioned Israel et al (1989) in a study using healthy individuals reported that, 
during exercise at approximately 60% of maximum oxygen consumption (VO2max), 
immersion in 25o C and 21o C water prevented a rise in core temperature. The same 
exercise regimen in 29o C water led to an increase in core temperature. Hence Israel et al 
(1989) concluded that, individuals of similar body composition and fitness level, performing 
cardiovascular exercise, in 21oC or 25oC water temperatures would benefit from the cooling 
effects resulting from immersion at these temperatures. These researchers also reported 
that very low intensity hydrotherapy could be performed in 29oC water as they had found 
that static immersion at that temperature had resulted in a fall in core temperature in the 
subjects in their study.  In the included studies, for this review, no particular reference to 
water temperature was made in regard to its influence on the outcomes measured. In fact 
only two of the studies in which physical training programmes were carried out mentioned 
the exact temperature of the water. Wadell, et al (2004) used a water temperature between 
33oC and 34oC and Perk, Perk and Bodén (1996) used water at 32oC. Severino, Morano 
and de Sousa Pinto (2007) and Rae and White (2009) conducted their interventions in 
swimming pools where the ambient temperature was probably within the afore-mentioned 
range. Wadell et al (2005) gave no indication of the water temperature used in their study. 
However, the four studies included in this review (Kurabayashi et al, 1997; Kurabayashi, 
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Machida and Kubota, 1998; Kurabayashi et al, 1998; Kurabayashi et al 2000) which looked 
at various cardiopulmonary outcomes in relation to a hydrotherapy breathing exercise 
regimen used hot spring water with a temperature of 38oC with no reported ill effects in the 
patients taking part. Although the breathing exercise interventions were conducted in hot 
spring water with a temperature of 38oC the exertion factor in these studies was minimal 
when compared to those involving a physical exercise hydrotherapy programme. Perhaps 
other factors which should be taken into account in such interventions are that variations in 
water temperature change the amount of thermal exchange through the skin (Choukroun, 
Kays and Varène, 1989). Wilmore and Costill (1994) pointed out that the thermal 
conductivity of water was approximately 26 times that of air and rapid loss of body heat 
occurred by conduction and convection during immersion. The passage of water over the 
body during aquatic exercise further accelerates the heat loss (Datta and Tipton, 2006). In 
this regard it was reported by Kurabayashi et al (1997) that the hot spring water, used in 
their study, could keep the body warm for longer as materials dissolved in the spring water 
act as a shield on the skin and prevent evaporation of heat. The gases eminating from the 
hot spring water could also have a mucolytic effect on the sputum of the patients with 
COPD and therefore aid with airway clearance.Kurabayashi, Machida and Kubota (1998) 
cited work done by Tei et al (1995) in which those researchers had found that a bath at 
41oC and a sauna bath at 60oC were effective in treating severe heart failure. However, 
Kurabayashi, Machida and Kubota (1998) reported that those temperatures were too high 
for 30 minutes of breathing exercises performed by patients with COPD immersed up to 
shoulder level and so they chose 38oC for their intervention.Kurabayashi, Machida and 
Kubota reported a significant increase in EF in patients who were immersed in 38oC water 
but the authors suggested that this improvement was possibly attributable to the hydraulic 
pressure exerted by the water. By assimilating all the above information this researcher 
concluded that there is enough proof to suggest that physical training exercise programmes 
for patients with COPD would be best conducted in thermoneutral water in the 32oC to 34oC 
range as this appears to be utilised in the COPD population with no adverse effects on the 
well-being of the patients and beneficial results are also realised in cardiopulmonary 
outcomes, strength and endurance outcomes, social and psychological  areas and ADL 
and HRQoL. However, the researcher would recommend that for breathing exercise 
programmes where the patient with COPD is merely standing in the water and exhaling into 
the water the water temperature used could probably be higher (38oC).  
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The hydrotherapy PR scenario appears to be well accepted by patients with COPD as 
many of them are elderly patients and find that the buoyancy of the water assists them to 
exercise more effectively than on land due to less impact being felt on arthritic joints (Rae 
and White 2009). Comments relating to social interaction during hydrotherapy and the 
psychological well-being expressed by patients with COPD, in the aquatic environment, 
were recorded in a study by Rae and White (2009). Hydrotherapy offers the benefits of low-
cost group training and may be seen as an attractive alternative by the patients with COPD 
who often grow bored with land-based PR (Perk, Perk and Bodén, 1996). The value of this 
enthusiasm is that the patients are more compliant with hydrotherapy exercise programmes 
than land-based exercise regimens. It was reported that, six months after the intervention 
by Rae and White (2009), 50% of the participants were still exercising in the swimming pool 
twice-weekly. The study by Rae and White (2009) also pinpointed the need for early 
intervention in the course of the disease in relation to improving the QoL of patients with 
COPD. These researchers also emphasised the importance of educating the patients with 
COPD in the early stages of the disease and, in particular, educating them regarding 
maximising the value of PR. 
 
Based on the information gleaned from this qualitiative systematic review, the researcher 
would like to present possible guidelines for the management of patients with COPD in the 
hydrotherapy environment: 
 Water temperature should preferably be within the range of 27 - 35ºC. 
 The physiotherapist should be aware of the reported drop in SBP (up to 14mmHg) 
as well as decrease in DBP (up to 6 mmHg) on static immersion of a subject in 
water. In order to counter this effect, circulatory exercises might be performed as a 
warm-up to the exercise session. 
 The type of exercises that could be included in the main part of the programme 
might include breathing out into the water (EMT); resistance type exercises utilizing 
water resistance, flotation devices as well as weights and dynamic upper limb and 
trunk exercises. An IMT device might be supplied to the patient for home-based 
training. 
 Structure of programme: 6 – 12 weeks duration (2 – 3 times per week) for a 
minimum of 30 minutes per session. 
 
Recommended outcome measures to assess the effectiveness of such a programme 
(measured prior to and after completion): 
 Ejection fraction - increase might indicate a positive outcome. 
 Mean HR (% HRpeak) – decrease might indicate a positive outcome. 
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 Percentage of FEV1 as well as PF – increase might indicate a positive outcome. 
 PaCO2 – decrease in levels might indicate a positive outcome. 
 Score on 0 – 10 Borg scale – decrease in score might indicate a positive outcome. 
 Exercise endurance as measured with ISWT – increase in distance walked might 
indicate a positive outcome. 
 Quality of life measured with either the SGRQ or CRQ – increase in scores might 
indicate a positive outcome. 
 
In summary, although there seems to be some evidence that hydrotherapy may improve 
some aspects of cardiopulmonary function in patients with COPD, increase their QoL and 
ability to perform ADL to some degree and contribute to psychological well-being with social 
integration, there are still many questions to be answered. Therefore the third hypothesis 
for this systematic review is rejected. One of the objectives of this review was to determine 
whether there was documented evidence relating to the anti-inflammatory effects of water-
based exercise in patients with COPD and no evidence was found in this regard. Therefore 
the second hypothesis for this systematic review is rejected. Only nine articles fulfilled the 
inclusion criteria for this review. Most of the included articles were of limited methodological 
quality and therefore hypothesis one for this review is rejected. 
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CHAPTER 6 
6. CONCLUSIONS AND RECOMMENDATIONS 
Evidence from small studies of low to moderate quality suggest that hydrotherapy may 
have some value in improving cardiopulmonary function, improving QoL and improving the 
performance of ADL in patients with COPD. The fact that hydrotherapy can offer a cost-
effective group therapy alternative to land-based PR programmes for patients with COPD 
can perhaps be taken into consideration when community-based or hospital-based PR 
programmes are being implemeted. Hydrotherapy programmes could be used as a primary 
care measure in patients with mild to moderate COPD or even in later stages of the disease 
when the patients are suffering from moderate to severe COPD. The introduction of an 
aquatic therapy programme in the early stages of COPD, perhaps in combination with 
patient education about the course of the disease, may lead to these patients managing 
their disease more effectively and perhaps slowing it‟s progression in severity. An increase 
in compliance in a hydrotherapy exercise programme, as opposed to a similar land-based 
exercise regimen, may occur because of the variety of exercise and lack of boredom 
offered by the aquatic environment. The social interaction and psychological well-being 
derived from hydrotherapy also appears to persuade patients to comply more readily with 
their PR programmes.  As it appears that EMT in the aquatic environment is effective in 
improving cardiopulmonary parameters in patients with COPD and that, the systemic 
muscular weaknesses and decrease in endurance levels, manifestated by the disease, can 
also be addressed in hydrotherapy programmes, it is perhaps feasible to consider that a 
combined PR programme incorporating both breathing exercises and a physical training 
component may be of benefit to the well-being of patients with COPD. 
 
A significant limitation to the quality of this review is the fact that so few studies have looked 
at the various aspects of hydrotherapy management in patients with COPD. Those studies 
in existence are small and of low to moderate methodological quality.This points to an area 
of research which is yet to be adequately addressed. There is an urgent need for a number 
of well-designed randomised controlled trials to investigate the role of breathing exercises 
in combination with hydrotherapy physical exercise programmes on pulmonary function and 
exercise endurance in patients with COPD. 
 
Investigation into the possible anti-inflammatory effects of water-based exercise in patients 
with COPD may also support the more frequent utilisation of this form of therapy in the 
future.   
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